RADHE MOHAN

TitleProfessor
InstitutionMD Anderson
DepartmentRadiation Physics
Address1400 Pressler St
Houston TX 77030-4008
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Titt U, Yang M, Wang X, Iga K, Fredette N, Schueler E, Lin SH, Zhu XR, Sahoo N, Koong AC, Zhang X, Mohan R. Design and validation of a synchrotron proton beam line for FLASH radiotherapy preclinical research experiments. Med Phys. 2021 Nov 20. PMID: 34800037.
      Citations:    Fields:    
    2. De B, Ludmir EB, Messick CA, Cagley MC, Morris VK, Das P, Minsky BD, Taniguchi CM, Smith GL, Koay EJ, Koong AC, Mohan R, Holliday EB. Prognostic impact of lymphopenia and neutrophil-lymphocyte ratio for patients with anal squamous cell carcinoma. J Gastrointest Oncol. 2021 Oct; 12(5):2412-2422. PMID: 34790402.
      Citations:    
    3. Engeseth GM, Hysing LB, Yepes P, Pettersen HES, Mohan R, Fuller CD, Stokkevåg CH, Wu R, Zhang X, Frank SJ, Gunn GB. Impact of RBE variations on risk estimates of temporal lobe necrosis in patients treated with intensity-modulated proton therapy for head and neck cancer. Acta Oncol. 2021 Sep 17; 1-8. PMID: 34534047.
      Citations:    Fields:    
    4. Zhu C, Mohan R, Lin SH, Jun G, Yaseen A, Jiang X, Wang Q, Cao W, Hobbs BP. Identifying Individualized Risk Profiles for Radiotherapy-Induced Lymphopenia Among Patients With Esophageal Cancer Using Machine Learning. JCO Clin Cancer Inform. 2021 09; 5:1044-1053. PMID: 34665662.
      Citations:    Fields:    Translation:Humans
    5. Geng H, Giaddui T, Cheng C, Zhong H, Ryu S, Liao Z, Yin FF, Gillin M, Mohan R, Xiao Y. A comparison of two methodologies for radiotherapy treatment plan optimization and QA for clinical trials. J Appl Clin Med Phys. 2021 Oct; 22(10):329-337. PMID: 34432946.
      Citations: 1     Fields:    Translation:Humans
    6. Kroese TE, Jairam J, Ruurda JP, Lin SH, Mohan R, Mook S, Haitjema S, Hoefer I, Haj Mohammad N, Peters M, van Hillegersberg R, van Rossum PSN. Severe lymphopenia acquired during chemoradiotherapy for esophageal cancer: Incidence and external validation of a prediction model. Radiother Oncol. 2021 Oct; 163:192-198. PMID: 34453954.
      Citations:    Fields:    
    7. He Y, Cazoulat G, Wu C, Peterson C, McCulloch M, Anderson B, Pollard-Larkin J, Balter P, Liao Z, Mohan R, Brock K. Geometric and dosimetric accuracy of deformable image registration between average-intensity images for 4DCT-based adaptive radiotherapy for non-small cell lung cancer. J Appl Clin Med Phys. 2021 Aug; 22(8):156-167. PMID: 34310827.
      Citations: 1     Fields:    Translation:Humans
    8. Xu T, Meng QH, Gilchrist SC, Lin SH, Lin R, Xu T, Milgrom SA, Gandhi SJ, Wu H, Zhao Y, Lopez-Mattei JC, Mohan R, Liao Z. Assessment of Prognostic Value of High-Sensitivity Cardiac Troponin T for Early Prediction of Chemoradiation Therapy-Induced Cardiotoxicity in Patients with Non-Small Cell Lung Cancer: A Secondary Analysis of a Prospective Randomized Trial. Int J Radiat Oncol Biol Phys. 2021 11 15; 111(4):907-916. PMID: 34302893.
      Citations:    Fields:    
    9. Palma G, Monti S, Pacelli R, Liao Z, Deasy JO, Mohan R, Cella L. Radiation Pneumonitis in Thoracic Cancer Patients: Multi-Center Voxel-Based Analysis. Cancers (Basel). 2021 Jul 15; 13(14). PMID: 34298767.
      Citations: 1     
    10. Deng W, Yang Y, Liu C, Bues M, Mohan R, Wong WW, Foote RH, Patel SH, Liu W. A Critical Review of LET-Based Intensity-Modulated Proton Therapy Plan Evaluation and Optimization for Head and Neck Cancer Management. Int J Part Ther. 2021; 8(1):36-49. PMID: 34285934.
      Citations:    
    11. Engeseth GM, He R, Mirkovic D, Yepes P, Mohamed ASR, Stieb S, Fuller CD, Wu R, Zhang X, Hysing LB, Pettersen HES, Stokkevåg CH, Mohan R, Frank SJ, Gunn GB. Mixed Effect Modeling of Dose and Linear Energy Transfer Correlations With Brain Image Changes After Intensity Modulated Proton Therapy for Skull Base Head and Neck Cancer. Int J Radiat Oncol Biol Phys. 2021 11 01; 111(3):684-692. PMID: 34153379.
      Citations: 1     Fields:    
    12. Skaarup M, Lundemann MJ, Darkner S, Jørgensen M, Marner L, Mirkovic D, Grosshans D, Peeler C, Mohan R, Vogelius IR, Appelt A. A framework for voxel-based assessment of biological effect after proton radiotherapy in pediatric brain cancer patients using multi-modal imaging. Med Phys. 2021 Jul; 48(7):4110-4121. PMID: 34021597.
      Citations: 1     Fields:    Translation:HumansCells
    13. Cella L, Monti S, Xu T, Liuzzi R, Stanzione A, Durante M, Mohan R, Liao Z, Palma G. Probing thoracic dose patterns associated to pericardial effusion and mortality in patients treated with photons and protons for locally advanced non-small-cell lung cancer. Radiother Oncol. 2021 07; 160:148-158. PMID: 33979653.
      Citations: 2     Fields:    Translation:Humans
    14. Mohan R, Liu AY, Brown PD, Mahajan A, Dinh J, Chung C, McAvoy S, McAleer MF, Lin SH, Li J, Ghia AJ, Zhu C, Sulman EP, de Groot JF, Heimberger AB, McGovern SL, Grassberger C, Shih H, Ellsworth S, Grosshans DR. Proton therapy reduces the likelihood of high-grade radiation-induced lymphopenia in glioblastoma patients: phase II randomized study of protons vs photons. Neuro Oncol. 2021 02 25; 23(2):284-294. PMID: 32750703.
      Citations: 7     Fields:    Translation:HumansCTClinical Trials
    15. Bronk L, Guan F, Patel D, Ma D, Kroger B, Wang X, Tran K, Yiu J, Stephan C, Debus J, Abdollahi A, Jäkel O, Mohan R, Titt U, Grosshans DR. Mapping the Relative Biological Effectiveness of Proton, Helium and Carbon Ions with High-Throughput Techniques. Cancers (Basel). 2020 Dec 05; 12(12). PMID: 33291477.
      Citations: 3     
    16. Hernandez M, Lee JJ, Yeap BY, Ye R, Foote RL, Busse P, Patel SH, Dagan R, Snider J, Mohammed N, Lin A, Blanchard P, Cantor SB, Teferra MY, Hutcheson K, Yepes P, Mohan R, Liao Z, DeLaney TF, Frank SJ. The Reality of Randomized Controlled Trials for Assessing the Benefit of Proton Therapy: Critically Examining the Intent-to-Treat Principle in the Presence of Insurance Denial. Adv Radiat Oncol. 2021 Mar-Apr; 6(2):100635. PMID: 33732960.
      Citations:    
    17. Abolfath R, Grosshans D, Mohan R. Oxygen depletion in FLASH ultra-high-dose-rate radiotherapy: A molecular dynamics simulation. Med Phys. 2020 Dec; 47(12):6551-6561. PMID: 33089504.
      Citations: 1     Fields:    Translation:Cells
    18. Xie X, Lin SH, Welsh JW, Wei X, Jin H, Mohan R, Liao Z, Xu T. Radiation-induced lymphopenia during chemoradiation therapy for non-small cell lung cancer is linked with age, lung V5, and XRCC1 rs25487 genotypes in lymphocytes. Radiother Oncol. 2021 01; 154:187-193. PMID: 32916236.
      Citations: 5     Fields:    Translation:HumansCells
    19. Bai X, Lim G, Grosshans D, Mohan R, Cao W. A biological effect-guided optimization approach using beam distal-edge avoidance for intensity-modulated proton therapy. Med Phys. 2020 Sep; 47(9):3816-3825. PMID: 32557747.
      Citations: 2     Fields:    Translation:HumansCells
    20. Vassiliev ON, Peterson CB, Grosshans DR, Mohan R. A simple model for calculating relative biological effectiveness of X-rays and gamma radiation in cell survival. Br J Radiol. 2020 Aug; 93(1112):20190949. PMID: 32464080.
      Citations: 1     Fields:    Translation:HumansAnimalsCells
    21. McNamara AL, Hall DC, Shusharina N, Liu A, Wei X, Ajdari A, Mohan R, Liao Z, Paganetti H. Perspectives on the model-based approach to proton therapy trials: A retrospective study of a lung cancer randomized trial. Radiother Oncol. 2020 06; 147:8-14. PMID: 32224318.
      Citations: 1     Fields:    Translation:Humans
    22. Xu C, Jin JY, Zhang M, Liu A, Wang J, Mohan R, Kong FS, Lin SH. The impact of the effective dose to immune cells on lymphopenia and survival of esophageal cancer after chemoradiotherapy. Radiother Oncol. 2020 05; 146:180-186. PMID: 32182504.
      Citations: 4     Fields:    Translation:Humans
    23. Lin SH, Hobbs BP, Verma V, Tidwell RS, Smith GL, Lei X, Corsini EM, Mok I, Wei X, Yao L, Wang X, Komaki RU, Chang JY, Chun SG, Jeter MD, Swisher SG, Ajani JA, Blum-Murphy M, Vaporciyan AA, Mehran RJ, Koong AC, Gandhi SJ, Hofstetter WL, Hong TS, Delaney TF, Liao Z, Mohan R. Randomized Phase IIB Trial of Proton Beam Therapy Versus Intensity-Modulated Radiation Therapy for Locally Advanced Esophageal Cancer. J Clin Oncol. 2020 05 10; 38(14):1569-1579. PMID: 32160096.
      Citations: 28     Fields:    Translation:HumansCTClinical Trials
    24. Ma D, Bronk L, Kerr M, Sobieski M, Chen M, Geng C, Yiu J, Wang X, Sahoo N, Cao W, Zhang X, Stephan C, Mohan R, Grosshans DR, Guan F. Exploring the advantages of intensity-modulated proton therapy: experimental validation of biological effects using two different beam intensity-modulation patterns. Sci Rep. 2020 02 21; 10(1):3199. PMID: 32081928.
      Citations: 2     Fields:    Translation:HumansCells
    25. Abolfath R, Peeler C, Mirkovic D, Mohan R, Grosshans D. A DNA damage multiscale model for NTCP in proton and hadron therapy. Med Phys. 2020 Apr; 47(4):2005-2012. PMID: 31955444.
      Citations:    Fields:    Translation:Humans
    26. Bright SJ, Flint DB, Chakraborty S, McFadden CH, Yoon DS, Bronk L, Titt U, Mohan R, Grosshans DR, Sumazin P, Shaitelman SF, Asaithamby A, Sawakuchi GO. Nonhomologous End Joining Is More Important Than Proton Linear Energy Transfer in Dictating Cell Death. Int J Radiat Oncol Biol Phys. 2019 12 01; 105(5):1119-1125. PMID: 31425731.
      Citations: 4     Fields:    Translation:HumansCells
    27. van Rossum PSN, Deng W, Routman DM, Liu AY, Xu C, Shiraishi Y, Peters M, Merrell KW, Hallemeier CL, Mohan R, Lin SH. Prediction of Severe Lymphopenia During Chemoradiation Therapy for Esophageal Cancer: Development and Validation of a Pretreatment Nomogram. Pract Radiat Oncol. 2020 Jan - Feb; 10(1):e16-e26. PMID: 31369887.
      Citations: 10     Fields:    Translation:Humans
    28. Newpower M, Schuemann J, Mohan R, Paganetti H, Titt U. Comparing 2 Monte Carlo Systems in Use for Proton Therapy Research. Int J Part Ther. 2019; 6(1):18-27. PMID: 31773045.
      Citations:    
    29. Cao W, Khabazian A, Yepes P, Lim G, Poenisch F, Grosshans D, Mohan R. Reply to Comment on 'Linear energy transfer incorporated intensity modulated proton therapy optimization'. Phys Med Biol. 2019 02 27; 64(5):058002. PMID: 30811349.
      Citations:    Fields:    Translation:Cells
    30. Palma G, Monti S, Xu T, Scifoni E, Yang P, Hahn SM, Durante M, Mohan R, Liao Z, Cella L. Spatial Dose Patterns Associated With Radiation Pneumonitis in a Randomized Trial Comparing Intensity-Modulated Photon Therapy With Passive Scattering Proton Therapy for Locally Advanced Non-Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys. 2019 08 01; 104(5):1124-1132. PMID: 30822531.
      Citations: 10     Fields:    Translation:Humans
    31. Paganetti H, Blakely E, Carabe-Fernandez A, Carlson DJ, Das IJ, Dong L, Grosshans D, Held KD, Mohan R, Moiseenko V, Niemierko A, Stewart RD, Willers H. Report of the AAPM TG-256 on the relative biological effectiveness of proton beams in radiation therapy. Med Phys. 2019 Mar; 46(3):e53-e78. PMID: 30661238.
      Citations: 27     Fields:    Translation:Humans
    32. Newpower M, Patel D, Bronk L, Guan F, Chaudhary P, McMahon SJ, Prise KM, Schettino G, Grosshans DR, Mohan R. Using the Proton Energy Spectrum and Microdosimetry to Model Proton Relative Biological Effectiveness. Int J Radiat Oncol Biol Phys. 2019 06 01; 104(2):316-324. PMID: 30731186.
      Citations: 5     Fields:    Translation:Cells
    33. Deng W, Xu C, Liu A, van Rossum PSN, Deng W, Liao Z, Koong AC, Mohan R, Lin SH. The relationship of lymphocyte recovery and prognosis of esophageal cancer patients with severe radiation-induced lymphopenia after chemoradiation therapy. Radiother Oncol. 2019 04; 133:9-15. PMID: 30935587.
      Citations: 14     Fields:    Translation:HumansCellsPHPublic Health
    34. Bai X, Lim G, Grosshans D, Mohan R, Cao W. Robust optimization to reduce the impact of biological effect variation from physical uncertainties in intensity-modulated proton therapy. Phys Med Biol. 2019 01 08; 64(2):025004. PMID: 30523932.
      Citations: 6     Fields:    Translation:HumansCells
    35. Ge S, Wang X, Liao Z, Zhang L, Sahoo N, Yang J, Guan F, Mohan R. Potential for Improvements in Robustness and Optimality of Intensity-Modulated Proton Therapy for Lung Cancer with 4-Dimensional Robust Optimization. Cancers (Basel). 2019 Jan 01; 11(1). PMID: 30609652.
      Citations: 5     
    36. Guan F, Geng C, Carlson DJ, Ma DH, Bronk L, Gates D, Wang X, Kry SF, Grosshans D, Mohan R. A mechanistic relative biological effectiveness model-based biological dose optimization for charged particle radiobiology studies. Phys Med Biol. 2018 12 21; 64(1):015008. PMID: 30523805.
      Citations: 1     Fields:    Translation:Humans
    37. Yepes P, Adair A, Frank SJ, Grosshans DR, Liao Z, Liu A, Mirkovic D, Poenisch F, Titt U, Wang Q, Mohan R. Fixed- versus Variable-RBE Computations for Intensity Modulated Proton Therapy. Adv Radiat Oncol. 2019 Jan-Mar; 4(1):156-167. PMID: 30706024.
      Citations: 3     
    38. Tucker SL, Xu T, Paganetti H, Deist T, Verma V, Choi N, Mohan R, Liao Z. Validation of Effective Dose as a Better Predictor of Radiation Pneumonitis Risk Than Mean Lung Dose: Secondary Analysis of a Randomized Trial. Int J Radiat Oncol Biol Phys. 2019 02 01; 103(2):403-410. PMID: 30291994.
      Citations: 7     Fields:    Translation:Humans
    39. Vassiliev ON, Kry SF, Wang HC, Peterson CB, Chang JY, Mohan R. Radiotherapy of lung cancers: FFF beams improve dose coverage at tumor periphery compromised by electronic disequilibrium. Phys Med Biol. 2018 09 28; 63(19):195007. PMID: 30189421.
      Citations: 5     Fields:    Translation:Humans
    40. Guan F, Geng C, Ma D, Bronk L, Kerr M, Li Y, Gates D, Kroger B, Sahoo N, Titt U, Grosshans D, Mohan R. RBE Model-Based Biological Dose Optimization for Proton Radiobiology Studies. Int J Part Ther. 2018; 5(1):160-171. PMID: 30338268.
      Citations: 7     
    41. Yang P, Xu T, Gomez DR, Deng W, Wei X, Elhalawani H, Jin H, Guan F, Mirkovic D, Xu Y, Mohan R, Liao Z. Patterns of Local-Regional Failure After Intensity Modulated Radiation Therapy or Passive Scattering Proton Therapy With Concurrent Chemotherapy for Non-Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys. 2019 01 01; 103(1):123-131. PMID: 30165127.
      Citations: 6     Fields:    Translation:Humans
    42. Dabaja BS, Hoppe BS, Plastaras JP, Newhauser W, Rosolova K, Flampouri S, Mohan R, Mikhaeel NG, Kirova Y, Specht L, Yahalom J. Proton therapy for adults with mediastinal lymphomas: the International Lymphoma Radiation Oncology Group guidelines. Blood. 2018 10 18; 132(16):1635-1646. PMID: 30108066.
      Citations: 17     Fields:    Translation:HumansPHPublic Health
    43. Lühr A, von Neubeck C, Pawelke J, Seidlitz A, Peitzsch C, Bentzen SM, Bortfeld T, Debus J, Deutsch E, Langendijk JA, Loeffler JS, Mohan R, Scholz M, Sørensen BS, Weber DC, Baumann M, Krause M. "Radiobiology of Proton Therapy": Results of an international expert workshop. Radiother Oncol. 2018 07; 128(1):56-67. PMID: 29861141.
      Citations: 19     Fields:    Translation:Humans
    44. Liao Z, Mohan R. Future of Protons Depends on Precision. J Clin Oncol. 2018 07 01; 36(19):2002. PMID: 29746224.
      Citations: 1     Fields:    Translation:Humans
    45. Haas-Kogan D, Indelicato D, Paganetti H, Esiashvili N, Mahajan A, Yock T, Flampouri S, MacDonald S, Fouladi M, Stephen K, Kalapurakal J, Terezakis S, Kooy H, Grosshans D, Makrigiorgos M, Mishra K, Poussaint TY, Cohen K, Fitzgerald T, Gondi V, Liu A, Michalski J, Mirkovic D, Mohan R, Perkins S, Wong K, Vikram B, Buchsbaum J, Kun L. National Cancer Institute Workshop on Proton Therapy for Children: Considerations Regarding Brainstem Injury. Int J Radiat Oncol Biol Phys. 2018 05 01; 101(1):152-168. PMID: 29619963.
      Citations: 26     Fields:    Translation:HumansCellsPHPublic Health
    46. Ahmed MM, Coleman CN, Mendonca M, Bentzen S, Vikram B, Seltzer SM, Goodhead D, Obcemea C, Mohan R, Prise KM, Capala J, Citrin D, Kao G, Aryankalayil M, Eke I, Buchsbaum JC, Prasanna PGS, Liu FF, Le QT, Teicher B, Kirsch DG, Smart D, Tepper J, Formenti S, Haas-Kogan D, Raben D, Mitchell J. Workshop Report for Cancer Research: Defining the Shades of Gy: Utilizing the Biological Consequences of Radiotherapy in the Development of New Treatment Approaches-Meeting Viewpoint. Cancer Res. 2018 05 01; 78(9):2166-2170. PMID: 29686020.
      Citations: 6     Fields:    Translation:Humans
    47. Fang P, Jiang W, Davuluri R, Xu C, Krishnan S, Mohan R, Koong AC, Hsu CC, Lin SH. High lymphocyte count during neoadjuvant chemoradiotherapy is associated with improved pathologic complete response in esophageal cancer. Radiother Oncol. 2018 09; 128(3):584-590. PMID: 29530432.
      Citations: 26     Fields:    Translation:Humans
    48. Nantavithya C, Gomez DR, Wei X, Komaki R, Liao Z, Lin SH, Jeter M, Nguyen QN, Li H, Zhang X, Poenisch F, Zhu XR, Balter PA, Feng L, Choi NC, Mohan R, Chang JY. Phase 2 Study of Stereotactic Body Radiation Therapy and Stereotactic Body Proton Therapy for High-Risk, Medically Inoperable, Early-Stage Non-Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys. 2018 07 01; 101(3):558-563. PMID: 29680255.
      Citations: 14     Fields:    Translation:HumansCTClinical Trials
    49. Vassiliev ON, Kry SF, Grosshans DR, Mohan R. Average stopping powers for electron and photon sources for radiobiological modeling and microdosimetric applications. Phys Med Biol. 2018 03 02; 63(5):055007. PMID: 29411712.
      Citations: 2     Fields:    Translation:Humans
    50. Mohan R, Das IJ, Ling CC. Dedicating "Empowering Intensity Modulated Proton Therapy Through Physics and Technology: An Overview" to the Memory of Dr Michael Goitein. Int J Radiat Oncol Biol Phys. 2018 03 01; 100(3):809-810. PMID: 29413298.
      Citations:    Fields:    
    51. Taleei R, Guan F, Peeler C, Bronk L, Patel D, Mirkovic D, Grosshans DR, Mohan R, Titt U. Erratum: "Monte Carlo simulations of 3 He ion physical characteristics in a water phantom and evaluation of radiobiological effectiveness" [Med. Phys. 43 (2), page range 761-776(2016)]. Med Phys. 2018 Mar; 45(3):1301. PMID: 29527699.
      Citations:    Fields:    
    52. Yepes P, Adair A, Grosshans D, Mirkovic D, Poenisch F, Titt U, Wang Q, Mohan R. Comparison of Monte Carlo and analytical dose computations for intensity modulated proton therapy. Phys Med Biol. 2018 02 09; 63(4):045003. PMID: 29339570.
      Citations: 10     Fields:    Translation:Humans
    53. Shusharina N, Liao Z, Mohan R, Liu A, Niemierko A, Choi N, Bortfeld T. Differences in lung injury after IMRT or proton therapy assessed by 18FDG PET imaging. Radiother Oncol. 2018 07; 128(1):147-153. PMID: 29352608.
      Citations: 9     Fields:    Translation:HumansPHPublic Health
    54. Liao Z, Lee JJ, Komaki R, Gomez DR, O'Reilly MS, Fossella FV, Blumenschein GR, Heymach JV, Vaporciyan AA, Swisher SG, Allen PK, Choi NC, DeLaney TF, Hahn SM, Cox JD, Lu CS, Mohan R. Bayesian Adaptive Randomization Trial of Passive Scattering Proton Therapy and Intensity-Modulated Photon Radiotherapy for Locally Advanced Non-Small-Cell Lung Cancer. J Clin Oncol. 2018 06 20; 36(18):1813-1822. PMID: 29293386.
      Citations: 80     Fields:    Translation:Humans
    55. Wu RY, Liu AY, Sio TT, Blanchard P, Wages C, Amin MV, Gunn GB, Titt U, Ye R, Suzuki K, Gillin MT, Zhu XR, Mohan R, Frank SJ. Intensity-Modulated Proton Therapy Adaptive Planning for Patients with Oropharyngeal Cancer. Int J Part Ther. 2017; 4(2):26-34. PMID: 31773006.
      Citations: 7     
    56. Mohan R, Held KD, Story MD, Grosshans D, Capala J. Proceedings of the National Cancer Institute Workshop on Charged Particle Radiobiology. Int J Radiat Oncol Biol Phys. 2018 03 15; 100(4):816-831. PMID: 29485053.
      Citations: 3     Fields:    Translation:Humans
    57. Cao W, Khabazian A, Yepes PP, Lim G, Poenisch F, Grosshans DR, Mohan R. Linear energy transfer incorporated intensity modulated proton therapy optimization. Phys Med Biol. 2017 12 19; 63(1):015013. PMID: 29131808.
      Citations: 13     Fields:    Translation:HumansCells
    58. Shiraishi Y, Fang P, Xu C, Song J, Krishnan S, Koay EJ, Mehran RJ, Hofstetter WL, Blum-Murphy M, Ajani JA, Komaki R, Minsky B, Mohan R, Hsu CC, Hobbs BP, Lin SH. Severe lymphopenia during neoadjuvant chemoradiation for esophageal cancer: A propensity matched analysis of the relative risk of proton versus photon-based radiation therapy. Radiother Oncol. 2018 07; 128(1):154-160. PMID: 29248170.
      Citations: 41     Fields:    Translation:HumansPHPublic Health
    59. Jeter MD, Gomez D, Nguyen QN, Komaki R, Zhang X, Zhu X, O'Reilly M, Fossella FV, Xu T, Wei X, Wang H, Yang W, Tsao A, Mohan R, Liao Z. Simultaneous Integrated Boost for Radiation Dose Escalation to the Gross Tumor Volume With Intensity Modulated (Photon) Radiation Therapy or Intensity Modulated Proton Therapy and Concurrent Chemotherapy for Stage II to III Non-Small Cell Lung Cancer: A Phase 1 Study. Int J Radiat Oncol Biol Phys. 2018 03 01; 100(3):730-737. PMID: 29248169.
      Citations: 4     Fields:    Translation:HumansCTClinical Trials
    60. Vassiliev ON, Grosshans DR, Mohan R. A new formalism for modelling parameters a and ß of the linear-quadratic model of cell survival for hadron therapy. Phys Med Biol. 2017 Oct 03; 62(20):8041-8059. PMID: 28832343.
      Citations: 4     Fields:    Translation:HumansCells
    61. Mohan R, Das IJ, Ling CC. Empowering Intensity Modulated Proton Therapy Through Physics and Technology: An Overview. Int J Radiat Oncol Biol Phys. 2017 10 01; 99(2):304-316. PMID: 28871980.
      Citations: 11     Fields:    Translation:HumansCells
    62. Chun SG, Solberg TD, Grosshans DR, Nguyen QN, Simone CB, Mohan R, Liao Z, Hahn SM, Herman JM, Frank SJ. The Potential of Heavy-Ion Therapy to Improve Outcomes for Locally Advanced Non-Small Cell Lung Cancer. Front Oncol. 2017; 7:201. PMID: 28929085.
      Citations: 2     
    63. Ulrich S, Wieser HP, Cao W, Mohan R, Bangert M. Impact of respiratory motion on variable relative biological effectiveness in 4D-dose distributions of proton therapy. Acta Oncol. 2017 Nov; 56(11):1420-1427. PMID: 28828913.
      Citations: 2     Fields:    Translation:HumansCells
    64. Mohan R, Peeler CR, Guan F, Bronk L, Cao W, Grosshans DR. Radiobiological issues in proton therapy. Acta Oncol. 2017 Nov; 56(11):1367-1373. PMID: 28826292.
      Citations: 15     Fields:    Translation:Humans
    65. Abolfath R, Peeler CR, Newpower M, Bronk L, Grosshans D, Mohan R. A model for relative biological effectiveness of therapeutic proton beams based on a global fit of cell survival data. Sci Rep. 2017 08 21; 7(1):8340. PMID: 28827691.
      Citations: 5     Fields:    Translation:HumansCells
    66. Chang JY, Verma V, Li M, Zhang W, Komaki R, Lu C, Allen PK, Liao Z, Welsh J, Lin SH, Gomez D, Jeter M, O'Reilly M, Zhu RX, Zhang X, Li H, Mohan R, Heymach JV, Vaporciyan AA, Hahn S, Cox JD. Proton Beam Radiotherapy and Concurrent Chemotherapy for Unresectable Stage III Non-Small Cell Lung Cancer: Final Results of a Phase 2 Study. JAMA Oncol. 2017 08 10; 3(8):e172032. PMID: 28727865.
      Citations: 48     Fields:    Translation:HumansCTClinical Trials
    67. Niedzielski JS, Yang J, Stingo F, Liao Z, Gomez D, Mohan R, Martel M, Briere T, Court L. A Novel Methodology using CT Imaging Biomarkers to Quantify Radiation Sensitivity in the Esophagus with Application to Clinical Trials. Sci Rep. 2017 07 20; 7(1):6034. PMID: 28729729.
      Citations: 6     Fields:    Translation:Humans
    68. Niedzielski JS, Yang J, Mohan R, Titt U, Mirkovic D, Stingo F, Liao Z, Gomez DR, Martel MK, Briere TM, Court LE. Differences in Normal Tissue Response in the Esophagus Between Proton and Photon Radiation Therapy for Non-Small Cell Lung Cancer Using In Vivo Imaging Biomarkers. Int J Radiat Oncol Biol Phys. 2017 11 15; 99(4):1013-1020. PMID: 29063837.
      Citations:    Fields:    Translation:Humans
    69. Oborn BM, Dowdell S, Metcalfe PE, Crozier S, Mohan R, Keall PJ. Future of medical physics: Real-time MRI-guided proton therapy. Med Phys. 2017 Aug; 44(8):e77-e90. PMID: 28547820.
      Citations: 22     Fields:    Translation:Humans
    70. Fave X, Zhang L, Yang J, Mackin D, Balter P, Gomez D, Followill D, Jones AK, Stingo F, Liao Z, Mohan R, Court L. Delta-radiomics features for the prediction of patient outcomes in non-small cell lung cancer. Sci Rep. 2017 04 03; 7(1):588. PMID: 28373718.
      Citations: 69     Fields:    Translation:Humans
    71. Grosshans DR, Mohan R, Gondi V, Shih HA, Mahajan A, Brown PD. The role of image-guided intensity modulated proton therapy in glioma. Neuro Oncol. 2017 04 01; 19(suppl_2):ii30-ii37. PMID: 28380636.
      Citations: 4     Fields:    Translation:Humans
    72. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 28139305.
      Citations: 17     Fields:    Translation:HumansCTClinical Trials
    73. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 29746223.
      Citations:    Fields:    Translation:Humans
    74. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 29726368.
      Citations: 1     Fields:    
    75. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 29527697.
      Citations:    Fields:    
    76. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 27354125.
      Citations: 38     Fields:    Translation:Humans
    77. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 28300378.
      Citations: 1     Fields:    Translation:Humans
    78. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 27919760.
      Citations: 56     Fields:    Translation:Humans
    79. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 28880368.
      Citations: 6     Fields:    Translation:HumansCells
    80. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 25506501.
      Citations: 4     
    81. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 27342249.
      Citations: 59     Fields:    Translation:Humans
    82. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 10973731.
      Citations: 4     Fields:    Translation:Animals
    83. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 9634946.
      Citations: 1     Fields:    Translation:HumansAnimals
    84. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 19660879.
      Citations: 85     Fields:    Translation:HumansPHPublic Health
    85. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 25413400.
      Citations: 23     Fields:    Translation:Humans
    86. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 8603858.
      Citations: 39     Fields:    Translation:HumansAnimalsCells
    87. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 31851954.
      Citations:    Fields:    Translation:HumansPHPublic Health
    88. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 31553958.
      Citations: 1     Fields:    
    89. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 32257950.
      Citations: 5     
    90. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 30562614.
      Citations: 5     Fields:    Translation:Humans
    91. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 29976504.
      Citations: 9     Fields:    Translation:Humans
    92. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 33127998.
      Citations: 2     Fields:    
    93. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 33665481.
      Citations:    
    94. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 33688489.
      Citations: 1     
    95. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 34168519.
      Citations:    
    96. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 34822721.
      Citations:    Fields:    
    97. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 34722808.
      Citations:    
    98. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 15001271.
      Citations: 68     Fields:    Translation:Humans
    99. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 15590191.
      Citations: 22     Fields:    Translation:HumansPHPublic Health
    100. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 16298001.
      Citations: 51     Fields:    Translation:HumansCTClinical Trials
    101. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 19305036.
      Citations: 53     Fields:    Translation:HumansPHPublic Health
    102. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 19810479.
      Citations: 47     Fields:    Translation:Humans
    103. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 23916884.
      Citations: 33     Fields:    Translation:Humans
    104. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 3093417.
      Citations: 6     Fields:    Translation:Humans
    105. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 3696069.
      Citations: 3     Fields:    Translation:Humans
    106. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 1903372.
      Citations: 6     Fields:    Translation:Humans
    107. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 7713795.
      Citations:    Fields:    Translation:PHPublic Health
    108. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 8175409.
      Citations: 1     Fields:    Translation:Humans
    109. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 9788426.
      Citations: 17     Fields:    Translation:Humans
    110. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 10619256.
      Citations:    Fields:    Translation:Humans
    111. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 15305468.
      Citations: 21     Fields:    Translation:Humans
    112. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 15519806.
      Citations: 8     Fields:    
    113. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 12722809.
      Citations: 18     Fields:    Translation:Humans
    114. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 12852544.
      Citations: 20     Fields:    
    115. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 16904517.
      Citations: 19     Fields:    Translation:Humans
    116. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 17022221.
      Citations: 10     Fields:    Translation:HumansCells
    117. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 17379442.
      Citations: 48     Fields:    Translation:Humans
    118. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 18937989.
      Citations: 49     Fields:    Translation:Humans
    119. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 19544791.
      Citations: 20     Fields:    
    120. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 20305334.
      Citations: 27     Fields:    Translation:Humans
    121. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 21719949.
      Citations: 12     Fields:    Translation:Humans
    122. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 22768989.
      Citations: 11     Fields:    Translation:Humans
    123. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 2247651.
      Citations: 5     Fields:    Translation:HumansCells
    124. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 3951411.
      Citations: 18     Fields:    Translation:Humans
    125. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 10421552.
      Citations: 2     Fields:    
    126. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 11865994.
      Citations: 2     Fields:    Translation:Humans
    127. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 11695776.
      Citations: 52     Fields:    Translation:Humans
    128. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 12722807.
      Citations: 35     Fields:    Translation:HumansCTClinical Trials
    129. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 12804710.
      Citations: 3     Fields:    Translation:Humans
    130. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 15895577.
      Citations: 60     Fields:    Translation:Humans
    131. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 16696457.
      Citations: 33     Fields:    Translation:Cells
    132. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 17634645.
      Citations: 31     Fields:    Translation:HumansPHPublic Health
    133. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 16682145.
      Citations: 91     Fields:    Translation:HumansPHPublic Health
    134. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 17153419.
      Citations: 28     Fields:    
    135. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 16839700.
      Citations: 20     Fields:    Translation:HumansPHPublic Health
    136. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 19231098.
      Citations: 18     Fields:    Translation:Humans
    137. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 21263173.
      Citations: 8     Fields:    Translation:Humans
    138. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 21625168.
      Citations: 4     Fields:    Translation:Humans
    139. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 20615629.
      Citations: 46     Fields:    Translation:Humans
    140. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 21377288.
      Citations: 20     Fields:    Translation:HumansPHPublic Health
    141. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 22320798.
      Citations: 1     Fields:    
    142. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 22920974.
      Citations: 9     Fields:    Translation:Humans
    143. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 22901421.
      Citations: 18     Fields:    Translation:Humans
    144. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 8310138.
      Citations: 1     Fields:    Translation:Humans
    145. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 2004961.
      Citations: 7     Fields:    Translation:HumansCTClinical Trials
    146. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 2032884.
      Citations: 71     Fields:    Translation:Humans
    147. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 3088413.
      Citations:    Fields:    Translation:Humans
    148. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 3104741.
      Citations: 5     Fields:    Translation:Humans
    149. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 3127669.
      Citations: 1     Fields:    Translation:Humans
    150. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 2231006.
      Citations: 9     Fields:    Translation:Humans
    151. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 7493836.
      Citations: 7     Fields:    Translation:Humans
    152. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 7700205.
      Citations:    Fields:    Translation:Humans
    153. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 8815373.
      Citations: 12     Fields:    Translation:Humans
    154. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 11395244.
      Citations: 14     Fields:    Translation:Humans
    155. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 11777642.
      Citations: 77     Fields:    Translation:HumansPHPublic Health
    156. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 12909241.
      Citations:    Fields:    Translation:Humans
    157. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 12074470.
      Citations: 7     Fields:    Translation:Humans
    158. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 10798692.
      Citations: 40     Fields:    Translation:Humans
    159. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 17321067.
      Citations: 93     Fields:    Translation:Humans
    160. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 17544596.
      Citations: 12     Fields:    Translation:HumansCells
    161. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 18722272.
      Citations: 35     Fields:    Translation:Humans
    162. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 3608441.
      Citations:    Fields:    Translation:Humans
    163. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 7642426.
      Citations: 3     Fields:    
    164. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 22320818.
      Citations: 88     Fields:    Translation:Humans
    165. Peeler CR, Mirkovic D, Titt U, Blanchard P, Gunther JR, Mahajan A, Mohan R, Grosshans DR. Clinical evidence of variable proton biological effectiveness in pediatric patients treated for ependymoma. Radiother Oncol. 2016 12; 121(3):395-401. PMID: 27863964.
      Citations: 47     Fields:    Translation:HumansCells
    166. Blanchard P, Wong AJ, Gunn GB, Garden AS, Mohamed ASR, Rosenthal DI, Crutison J, Wu R, Zhang X, Zhu XR, Mohan R, Amin MV, Fuller CD, Frank SJ. Toward a model-based patient selection strategy for proton therapy: External validation of photon-derived normal tissue complication probability models in a head and neck proton therapy cohort. Radiother Oncol. 2016 12; 121(3):381-386. PMID: 27641784.
      Citations: 20     Fields:    Translation:HumansPHPublic Health
    167. Niedzielski JS, Yang J, Liao Z, Gomez DR, Stingo F, Mohan R, Martel MK, Briere TM, Court LE. (18)F-Fluorodeoxyglucose Positron Emission Tomography Can Quantify and Predict Esophageal Injury During Radiation Therapy. Int J Radiat Oncol Biol Phys. 2016 11 01; 96(3):670-8. PMID: 27681764.
      Citations: 6     Fields:    Translation:HumansPHPublic Health
    168. Giaddui T, Chen W, Yu J, Lin L, Simone CB, Yuan L, Gong YU, Wu QJ, Mohan R, Zhang X, Bluett JB, Gillin M, Moore K, O'Meara E, Presley J, Bradley JD, Liao Z, Galvin J, Xiao Y. Establishing the feasibility of the dosimetric compliance criteria of RTOG 1308: phase III randomized trial comparing overall survival after photon versus proton radiochemotherapy for inoperable stage II-IIIB NSCLC. Radiat Oncol. 2016 May 04; 11:66. PMID: 27142674.
      Citations: 30     Fields:    Translation:HumansCTClinical Trials
    169. Yepes PP, Eley JG, Liu A, Mirkovic D, Randeniya S, Titt U, Mohan R. Validation of a track repeating algorithm for intensity modulated proton therapy: clinical cases study. Phys Med Biol. 2016 Apr 07; 61(7):2633-45. PMID: 26961764.
      Citations: 6     Fields:    Translation:Humans
    170. Matney JE, Park PC, Li H, Court LE, Zhu XR, Dong L, Liu W, Mohan R. Perturbation of water-equivalent thickness as a surrogate for respiratory motion in proton therapy. J Appl Clin Med Phys. 2016 03 08; 17(2):368-378. PMID: 27074459.
      Citations: 4     Fields:    Translation:Humans
    171. Wang XS, Shi Q, Williams LA, Komaki R, Gomez DR, Lin SH, Chang JY, O'Reilly MS, Bokhari RH, Cox JD, Mohan R, Cleeland CS, Liao Z. Prospective Study of Patient-Reported Symptom Burden in Patients With Non-Small-Cell Lung Cancer Undergoing Proton or Photon Chemoradiation Therapy. J Pain Symptom Manage. 2016 05; 51(5):832-8. PMID: 26891607.
      Citations: 14     Fields:    Translation:Humans
    172. Gunn GB, Blanchard P, Garden AS, Zhu XR, Fuller CD, Mohamed AS, Morrison WH, Phan J, Beadle BM, Skinner HD, Sturgis EM, Kies MS, Hutcheson KA, Rosenthal DI, Mohan R, Gillin MT, Frank SJ. Clinical Outcomes and Patterns of Disease Recurrence After Intensity Modulated Proton Therapy for Oropharyngeal Squamous Carcinoma. Int J Radiat Oncol Biol Phys. 2016 May 01; 95(1):360-367. PMID: 27084653.
      Citations: 29     Fields:    Translation:HumansPHPublic Health
    173. Taleei R, Guan F, Peeler C, Bronk L, Patel D, Mirkovic D, Grosshans DR, Mohan R, Titt U. Monte Carlo simulations of ³He ion physical characteristics in a water phantom and evaluation of radiobiological effectiveness. Med Phys. 2016 Feb; 43(2):761-76. PMID: 26843239.
      Citations: 3     Fields:    
    174. Guan F, Peeler C, Bronk L, Geng C, Taleei R, Randeniya S, Ge S, Mirkovic D, Grosshans D, Mohan R, Titt U. Analysis of the track- and dose-averaged LET and LET spectra in proton therapy using the geant4 Monte Carlo code. Med Phys. 2015 Nov; 42(11):6234-47. PMID: 26520716.
      Citations: 24     Fields:    Translation:HumansCells
    175. Titt U, Sell M, Unkelbach J, Bangert M, Mirkovic D, Oelfke U, Mohan R. Degradation of proton depth dose distributions attributable to microstructures in lung-equivalent material. Med Phys. 2015 Nov; 42(11):6425-32. PMID: 26520732.
      Citations: 5     Fields:    Translation:HumansCells
    176. Niedzielski JS, Yang J, Stingo F, Martel MK, Mohan R, Gomez DR, Briere TM, Liao Z, Court LE. Objectively Quantifying Radiation Esophagitis With Novel Computed Tomography-Based Metrics. Int J Radiat Oncol Biol Phys. 2016 Feb 01; 94(2):385-93. PMID: 26675063.
      Citations: 6     Fields:    Translation:HumansPHPublic Health
    177. Guan F, Bronk L, Titt U, Lin SH, Mirkovic D, Kerr MD, Zhu XR, Dinh J, Sobieski M, Stephan C, Peeler CR, Taleei R, Mohan R, Grosshans DR. Spatial mapping of the biologic effectiveness of scanned particle beams: towards biologically optimized particle therapy. Sci Rep. 2015 May 18; 5:9850. PMID: 25984967.
      Citations: 35     Fields:    Translation:HumansCells
    178. Kry SF, Olch A, Mohan R. Comment on "Monte Carlo evaluations of the absorbed dose and quality dependence of Al2O3 in radiotherapy photon beams" [Med. Phys. 36(10), 4421-4424 (2009)]. Med Phys. 2015 May; 42(5):2648-9. PMID: 25979056.
      Citations:    Fields:    
    179. Li H, Zhang X, Park P, Liu W, Chang J, Liao Z, Frank S, Li Y, Poenisch F, Mohan R, Gillin M, Zhu R. Robust optimization in intensity-modulated proton therapy to account for anatomy changes in lung cancer patients. Radiother Oncol. 2015 Mar; 114(3):367-72. PMID: 25708992.
      Citations: 18     Fields:    Translation:Humans
    180. Frank SJ, Cox JD, Gillin M, Mohan R, Garden AS, Rosenthal DI, Gunn GB, Weber RS, Kies MS, Lewin JS, Munsell MF, Palmer MB, Sahoo N, Zhang X, Liu W, Zhu XR. Multifield optimization intensity modulated proton therapy for head and neck tumors: a translation to practice. Int J Radiat Oncol Biol Phys. 2014 Jul 15; 89(4):846-53. PMID: 24867532.
      Citations: 44     Fields:    Translation:Humans
    181. Zhu Z, Liu W, Gillin M, Gomez DR, Komaki R, Cox JD, Mohan R, Chang JY. Assessing the robustness of passive scattering proton therapy with regard to local recurrence in stage III non-small cell lung cancer: a secondary analysis of a phase II trial. Radiat Oncol. 2014 May 06; 9:108. PMID: 24886059.
      Citations: 4     Fields:    Translation:HumansCTClinical Trials
    182. Wen J, Liu H, Wang Q, Liu Z, Li Y, Xiong H, Xu T, Li P, Wang LE, Gomez DR, Mohan R, Komaki R, Liao Z, Wei Q. Genetic variants of the LIN28B gene predict severe radiation pneumonitis in patients with non-small cell lung cancer treated with definitive radiation therapy. Eur J Cancer. 2014 Jul; 50(10):1706-1716. PMID: 24780874.
      Citations: 18     Fields:    Translation:Humans
    183. Gomez DR, Poenisch F, Mohan R. In reply to Mihaildis. Int J Radiat Oncol Biol Phys. 2014 Mar 01; 88(3):754. PMID: 24521687.
      Citations:    Fields:    Translation:Humans
    184. Liu W, Mohan R, Park P, Liu Z, Li H, Li X, Li Y, Wu R, Sahoo N, Dong L, Zhu XR, Grosshans DR. Dosimetric benefits of robust treatment planning for intensity modulated proton therapy for base-of-skull cancers. Pract Radiat Oncol. 2014 Nov-Dec; 4(6):384-91. PMID: 25407859.
      Citations: 21     Fields:    Translation:Humans
    185. Robertson D, Hui C, Archambault L, Mohan R, Beddar S. Optical artefact characterization and correction in volumetric scintillation dosimetry. Phys Med Biol. 2014 Jan 06; 59(1):23-42. PMID: 24321820.
      Citations: 7     Fields:    
    186. Zhang X, Lin SH, Fang B, Gillin M, Mohan R, Chang JY. Therapy-resistant cancer stem cells have differing sensitivity to photon versus proton beam radiation. J Thorac Oncol. 2013 Dec; 8(12):1484-91. PMID: 24389430.
      Citations: 20     Fields:    Translation:HumansCells
    187. Perles LA, Mirkovic D, Anand A, Titt U, Mohan R. LET dependence of the response of EBT2 films in proton dosimetry modeled as a bimolecular chemical reaction. Phys Med Biol. 2013 Dec 07; 58(23):8477-91. PMID: 24240474.
      Citations: 6     Fields:    Translation:Cells
    188. Matney J, Park PC, Bluett J, Chen YP, Liu W, Court LE, Liao Z, Li H, Mohan R. Effects of respiratory motion on passively scattered proton therapy versus intensity modulated photon therapy for stage III lung cancer: are proton plans more sensitive to breathing motion? Int J Radiat Oncol Biol Phys. 2013 Nov 01; 87(3):576-82. PMID: 24074932.
      Citations: 14     Fields:    Translation:Humans
    189. Gomez DR, Poenisch F, Pinnix CC, Sheu T, Chang JY, Memon N, Mohan R, Rozner MA, Dougherty AH. Malfunctions of implantable cardiac devices in patients receiving proton beam therapy: incidence and predictors. Int J Radiat Oncol Biol Phys. 2013 Nov 01; 87(3):570-5. PMID: 24074931.
      Citations: 9     Fields:    Translation:Humans
    190. Mori S, Dong L, Starkschall G, Mohan R, Chen GT. A serial 4DCT study to quantify range variations in charged particle radiotherapy of thoracic cancers. J Radiat Res. 2014 Mar 01; 55(2):309-19. PMID: 24142967.
      Citations: 6     Fields:    Translation:HumansCTClinical Trials
    191. Mohan R, Mahajan A, Minsky BD. New strategies in radiation therapy: exploiting the full potential of protons. Clin Cancer Res. 2013 Dec 01; 19(23):6338-43. PMID: 24077353.
      Citations: 5     Fields:    Translation:Humans
    192. Tucker SL, Liao Z, Dinh J, Bian SX, Mohan R, Martel MK, Grosshans DR. Is there an impact of heart exposure on the incidence of radiation pneumonitis? Analysis of data from a large clinical cohort. Acta Oncol. 2014 May; 53(5):590-6. PMID: 23992110.
      Citations: 9     Fields:    Translation:Humans
    193. Quan EM, Liu W, Wu R, Li Y, Frank SJ, Zhang X, Zhu XR, Mohan R. Preliminary evaluation of multifield and single-field optimization for the treatment planning of spot-scanning proton therapy of head and neck cancer. Med Phys. 2013 Aug; 40(8):081709. PMID: 23927306.
      Citations: 20     Fields:    Translation:Humans
    194. Park PC, Cheung JP, Zhu XR, Lee AK, Sahoo N, Tucker SL, Liu W, Li H, Mohan R, Court LE, Dong L. Statistical assessment of proton treatment plans under setup and range uncertainties. Int J Radiat Oncol Biol Phys. 2013 Aug 01; 86(5):1007-13. PMID: 23688812.
      Citations: 12     Fields:    Translation:Humans
    195. Liu W, Frank SJ, Li X, Li Y, Park PC, Dong L, Ronald Zhu X, Mohan R. Effectiveness of robust optimization in intensity-modulated proton therapy planning for head and neck cancers. Med Phys. 2013 May; 40(5):051711. PMID: 23635259.
      Citations: 42     Fields:    Translation:Humans
    196. Zhu XR, Poenisch F, Lii M, Sawakuchi GO, Titt U, Bues M, Song X, Zhang X, Li Y, Ciangaru G, Li H, Taylor MB, Suzuki K, Mohan R, Gillin MT, Sahoo N. Commissioning dose computation models for spot scanning proton beams in water for a commercially available treatment planning system. Med Phys. 2013 Apr; 40(4):041723. PMID: 23556893.
      Citations: 26     Fields:    
    197. Liu W, Frank SJ, Li X, Li Y, Zhu RX, Mohan R. PTV-based IMPT optimization incorporating planning risk volumes vs robust optimization. Med Phys. 2013 Feb; 40(2):021709. PMID: 23387732.
      Citations: 25     Fields:    Translation:Humans
    198. Pang Q, Wei Q, Xu T, Yuan X, Lopez Guerra JL, Levy LB, Liu Z, Gomez DR, Zhuang Y, Wang LE, Mohan R, Komaki R, Liao Z. Functional promoter variant rs2868371 of HSPB1 is associated with risk of radiation pneumonitis after chemoradiation for non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2013 Apr 01; 85(5):1332-9. PMID: 23374503.
      Citations: 19     Fields:    Translation:Humans
    199. Welsh J, Amini A, Ciura K, Nguyen N, Palmer M, Allen PK, Paolini M, Liao Z, Bluett J, Mohan R, Gomez D, Cox JD, Komaki R, Chang JY. Evaluating proton stereotactic body radiotherapy to reduce chest wall dose in the treatment of lung cancer. Med Dosim. 2013; 38(4):442-447. PMID: 24200220.
      Citations: 7     Fields:    Translation:Humans
    200. Zhang X, Fang B, Mohan R, Chang JY. Coxsackie-adenovirus receptor as a novel marker of stem cells in treatment-resistant non-small cell lung cancer. Radiother Oncol. 2012 Nov; 105(2):250-7. PMID: 23022172.
      Citations: 6     Fields:    Translation:HumansAnimalsCells
    201. Yang M, Zhu XR, Park PC, Titt U, Mohan R, Virshup G, Clayton JE, Dong L. Comprehensive analysis of proton range uncertainties related to patient stopping-power-ratio estimation using the stoichiometric calibration. Phys Med Biol. 2012 Jul 07; 57(13):4095-115. PMID: 22678123.
      Citations: 53     Fields:    Translation:Humans
    202. Tucker SL, Michalski JM, Bosch WR, Mohan R, Dong L, Winter K, Purdy JA, Cox JD. Use of fractional dose-volume histograms to model risk of acute rectal toxicity among patients treated on RTOG 94-06. Radiother Oncol. 2012 Jul; 104(1):109-13. PMID: 22673726.
      Citations: 5     Fields:    Translation:Humans
    203. Xu T, Wei Q, Lopez Guerra JL, Wang LE, Liu Z, Gomez D, O'Reilly M, Lin SH, Zhuang Y, Levy LB, Mohan R, Zhou H, Liao Z. HSPB1 gene polymorphisms predict risk of mortality for US patients after radio(chemo)therapy for non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2012 Oct 01; 84(2):e229-35. PMID: 22608953.
      Citations: 5     Fields:    Translation:Humans
    204. Tucker SL, Mohan R, Liengsawangwong R, Martel MK, Liao Z. Predicting pneumonitis risk: a dosimetric alternative to mean lung dose. Int J Radiat Oncol Biol Phys. 2013 Feb 01; 85(2):522-7. PMID: 22580121.
      Citations: 11     Fields:    Translation:Humans
    205. Tucker SL, Li M, Xu T, Gomez D, Yuan X, Yu J, Liu Z, Yin M, Guan X, Wang LE, Wei Q, Mohan R, Vinogradskiy Y, Martel M, Liao Z. Incorporating single-nucleotide polymorphisms into the Lyman model to improve prediction of radiation pneumonitis. Int J Radiat Oncol Biol Phys. 2013 Jan 01; 85(1):251-7. PMID: 22541966.
      Citations: 24     Fields:    Translation:Humans
    206. Koay EJ, Lege D, Mohan R, Komaki R, Cox JD, Chang JY. Adaptive/nonadaptive proton radiation planning and outcomes in a phase II trial for locally advanced non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2012 Dec 01; 84(5):1093-100. PMID: 22543217.
      Citations: 21     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    207. Wang J, Lin SH, Dong L, Balter P, Mohan R, Komaki R, Cox JD, Starkschall G. Quantifying the interfractional displacement of the gastroesophageal junction during radiation therapy for esophageal cancer. Int J Radiat Oncol Biol Phys. 2012 Jun 01; 83(2):e273-80. PMID: 22440040.
      Citations: 10     Fields:    Translation:Humans
    208. Lopez Guerra JL, Gomez DR, Zhuang Y, Levy LB, Eapen G, Liu H, Mohan R, Komaki R, Cox JD, Liao Z. Changes in pulmonary function after three-dimensional conformal radiotherapy, intensity-modulated radiotherapy, or proton beam therapy for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2012 Jul 15; 83(4):e537-43. PMID: 22420964.
      Citations: 20     Fields:    Translation:Humans
    209. Lin SH, Komaki R, Liao Z, Wei C, Myles B, Guo X, Palmer M, Mohan R, Swisher SG, Hofstetter WL, Ajani JA, Cox JD. Proton beam therapy and concurrent chemotherapy for esophageal cancer. Int J Radiat Oncol Biol Phys. 2012 Jul 01; 83(3):e345-51. PMID: 22417808.
      Citations: 36     Fields:    Translation:HumansPHPublic Health
    210. Archambault L, Poenisch F, Sahoo N, Robertson D, Lee A, Gillin MT, Mohan R, Beddar S. Verification of proton range, position, and intensity in IMPT with a 3D liquid scintillator detector system. Med Phys. 2012 Mar; 39(3):1239-46. PMID: 22380355.
      Citations: 13     Fields:    
    211. Tucker SL, Dong L, Michalski JM, Bosch WR, Winter K, Cox JD, Purdy JA, Mohan R. Do intermediate radiation doses contribute to late rectal toxicity? An analysis of data from radiation therapy oncology group protocol 94-06. Int J Radiat Oncol Biol Phys. 2012 Oct 01; 84(2):390-5. PMID: 22342302.
      Citations: 13     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    212. Zhang X, Liu W, Li Y, Li X, Quan M, Mohan R, Anand A, Sahoo N, Gillin M, Zhu XR. Parameterization of multiple Bragg curves for scanning proton beams using simultaneous fitting of multiple curves. Phys Med Biol. 2011 Dec 21; 56(24):7725-35. PMID: 22085829.
      Citations: 7     Fields:    
    213. Jiang ZQ, Yang K, Komaki R, Wei X, Tucker SL, Zhuang Y, Martel MK, Vedam S, Balter P, Zhu G, Gomez D, Lu C, Mohan R, Cox JD, Liao Z. Long-term clinical outcome of intensity-modulated radiotherapy for inoperable non-small cell lung cancer: the MD Anderson experience. Int J Radiat Oncol Biol Phys. 2012 May 01; 83(1):332-9. PMID: 22079735.
      Citations: 50     Fields:    Translation:HumansPHPublic Health
    214. Chang JY, Komaki R, Lu C, Wen HY, Allen PK, Tsao A, Gillin M, Mohan R, Cox JD. Phase 2 study of high-dose proton therapy with concurrent chemotherapy for unresectable stage III nonsmall cell lung cancer. Cancer. 2011 Oct 15; 117(20):4707-13. PMID: 21437893.
      Citations: 55     Fields:    Translation:HumansCTClinical Trials
    215. Chang JY, Komaki R, Wen HY, De Gracia B, Bluett JB, McAleer MF, Swisher SG, Gillin M, Mohan R, Cox JD. Toxicity and patterns of failure of adaptive/ablative proton therapy for early-stage, medically inoperable non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2011 Aug 01; 80(5):1350-7. PMID: 21251767.
      Citations: 29     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    216. Tsunashima Y, Vedam S, Dong L, Umezawa M, Balter P, Mohan R. The precision of respiratory-gated delivery of synchrotron-based pulsed beam proton therapy. Phys Med Biol. 2010 Dec 21; 55(24):7633-47. PMID: 21113089.
      Citations: 6     Fields:    Translation:Humans
    217. Titt U, Mirkovic D, Sawakuchi GO, Perles LA, Newhauser WD, Taddei PJ, Mohan R. Adjustment of the lateral and longitudinal size of scanned proton beam spots using a pre-absorber to optimize penumbrae and delivery efficiency. Phys Med Biol. 2010 Dec 07; 55(23):7097-106. PMID: 21076194.
      Citations: 8     Fields:    Translation:HumansCellsPHPublic Health
    218. Sawakuchi GO, Mirkovic D, Perles LA, Sahoo N, Zhu XR, Ciangaru G, Suzuki K, Gillin MT, Mohan R, Titt U. An MCNPX Monte Carlo model of a discrete spot scanning proton beam therapy nozzle. Med Phys. 2010 Sep; 37(9):4960-70. PMID: 20964215.
      Citations: 20     Fields:    
    219. Starkschall G, Balter P, Britton K, McAleer MF, Cox JD, Mohan R. Interfractional reproducibility of lung tumor location using various methods of respiratory motion mitigation. Int J Radiat Oncol Biol Phys. 2011 Feb 01; 79(2):596-601. PMID: 20638189.
      Citations: 4     Fields:    Translation:Humans
    220. Tucker SL, Dong L, Bosch WR, Michalski J, Winter K, Mohan R, Purdy JA, Kuban D, Lee AK, Cheung MR, Thames HD, Cox JD. Late rectal toxicity on RTOG 94-06: analysis using a mixture Lyman model. Int J Radiat Oncol Biol Phys. 2010 Nov 15; 78(4):1253-60. PMID: 20598811.
      Citations: 20     Fields:    Translation:HumansPHPublic Health
    221. Sawakuchi GO, Zhu XR, Poenisch F, Suzuki K, Ciangaru G, Titt U, Anand A, Mohan R, Gillin MT, Sahoo N. Experimental characterization of the low-dose envelope of spot scanning proton beams. Phys Med Biol. 2010 Jun 21; 55(12):3467-78. PMID: 20508318.
      Citations: 15     Fields:    
    222. Yang M, Virshup G, Clayton J, Zhu XR, Mohan R, Dong L. Theoretical variance analysis of single- and dual-energy computed tomography methods for calculating proton stopping power ratios of biological tissues. Phys Med Biol. 2010 Mar 07; 55(5):1343-62. PMID: 20145291.
      Citations: 50     Fields:    Translation:Humans
    223. Sawakuchi GO, Titt U, Mirkovic D, Ciangaru G, Zhu XR, Sahoo N, Gillin MT, Mohan R. Monte Carlo investigation of the low-dose envelope from scanned proton pencil beams. Phys Med Biol. 2010 Feb 07; 55(3):711-21. PMID: 20071752.
      Citations: 17     Fields:    
    224. Tucker SL, Jin H, Wei X, Wang S, Martel MK, Komaki R, Liu HH, Mohan R, Chen Y, Cox JD, Liao Z. Impact of toxicity grade and scoring system on the relationship between mean lung dose and risk of radiation pneumonitis in a large cohort of patients with non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2010 Jul 01; 77(3):691-8. PMID: 19836159.
      Citations: 15     Fields:    Translation:Humans
    225. Mohan R. Dueling Technologies: in regard to Ling et al. (Int J Radiat Oncol Biol Phys 2008;72:575-581). Int J Radiat Oncol Biol Phys. 2009 Sep 01; 75(1):6-7; discussion 8-9. PMID: 19695433.
      Citations: 2     Fields:    
    226. Liao ZX, Komaki RR, Thames HD, Liu HH, Tucker SL, Mohan R, Martel MK, Wei X, Yang K, Kim ES, Blumenschein G, Hong WK, Cox JD. Influence of technologic advances on outcomes in patients with unresectable, locally advanced non-small-cell lung cancer receiving concomitant chemoradiotherapy. Int J Radiat Oncol Biol Phys. 2010 Mar 01; 76(3):775-81. PMID: 19515503.
      Citations: 93     Fields:    Translation:Humans
    227. Pönisch F, Archambault L, Briere TM, Sahoo N, Mohan R, Beddar S, Gillin MT. Liquid scintillator for 2D dosimetry for high-energy photon beams. Med Phys. 2009 May; 36(5):1478-85. PMID: 19544763.
      Citations: 18     Fields:    
    228. Taddei PJ, Mirkovic D, Fontenot JD, Giebeler A, Zheng Y, Kornguth D, Mohan R, Newhauser WD. Stray radiation dose and second cancer risk for a pediatric patient receiving craniospinal irradiation with proton beams. Phys Med Biol. 2009 Apr 21; 54(8):2259-75. PMID: 19305045.
      Citations: 34     Fields:    Translation:Humans
    229. Newhauser WD, Fontenot JD, Taddei PJ, Mirkovic D, Giebeler A, Zhang R, Mahajan A, Kornguth D, Stovall M, Yepes P, Woo S, Mohan R. Contemporary Proton Therapy Systems Adequately Protect Patients from Exposure to Stray Radiation. AIP Conf Proc. 2009 Mar 10; 1099(1):450-455. PMID: 20844607.
      Citations: 6     
    230. Kry SF, Howell RM, Polf J, Mohan R, Vassiliev ON. Treatment vault shielding for a flattening filter-free medical linear accelerator. Phys Med Biol. 2009 Mar 07; 54(5):1265-73. PMID: 19190359.
      Citations: 5     Fields:    Translation:Humans
    231. Pan X, Zhang X, Li Y, Mohan R, Liao Z. Impact of using different four-dimensional computed tomography data sets to design proton treatment plans for distal esophageal cancer. Int J Radiat Oncol Biol Phys. 2009 Feb 01; 73(2):601-9. PMID: 19147024.
      Citations: 5     Fields:    Translation:Humans
    232. Vassiliev ON, Kry SF, Chang JY, Balter PA, Titt U, Mohan R. Stereotactic radiotherapy for lung cancer using a flattening filter free Clinac. J Appl Clin Med Phys. 2009 Jan 27; 10(1):14-21. PMID: 19223837.
      Citations: 31     Fields:    Translation:Humans
    233. Li H, Mohan R, Zhu XR. Scatter kernel estimation with an edge-spread function method for cone-beam computed tomography imaging. Phys Med Biol. 2008 Dec 07; 53(23):6729-48. PMID: 18997269.
      Citations: 17     Fields:    Translation:Humans
    234. Britton KR, Starkschall G, Liu H, Chang JY, Bilton S, Ezhil M, John-Baptiste S, Kantor M, Cox JD, Komaki R, Mohan R. Consequences of anatomic changes and respiratory motion on radiation dose distributions in conformal radiotherapy for locally advanced non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2009 Jan 01; 73(1):94-102. PMID: 18929448.
      Citations: 16     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    235. Tucker SL, Liu HH, Liao Z, Wei X, Wang S, Jin H, Komaki R, Martel MK, Mohan R. Analysis of radiation pneumonitis risk using a generalized Lyman model. Int J Radiat Oncol Biol Phys. 2008 Oct 01; 72(2):568-74. PMID: 18793959.
      Citations: 28     Fields:    Translation:Humans
    236. Zhang X, Zhao KL, Guerrero TM, McGuire SE, Yaremko B, Komaki R, Cox JD, Hui Z, Li Y, Newhauser WD, Mohan R, Liao Z. Four-dimensional computed tomography-based treatment planning for intensity-modulated radiation therapy and proton therapy for distal esophageal cancer. Int J Radiat Oncol Biol Phys. 2008 Sep 01; 72(1):278-87. PMID: 18722278.
      Citations: 40     Fields:    Translation:HumansPHPublic Health
    237. Rosen B, Starkschall G, Britton K, Mohan R, Cox JD. Utility of four-dimensional computed tomography for analysis of intrafractional and interfractional variation in lung volumes. Int J Radiat Oncol Biol Phys. 2008 Sep 01; 72(1):288-94. PMID: 18722279.
      Citations: 2     Fields:    Translation:Humans
    238. Wang H, Krishnan S, Wang X, Beddar AS, Briere TM, Crane CH, Mohan R, Dong L. Improving soft-tissue contrast in four-dimensional computed tomography images of liver cancer patients using a deformable image registration method. Int J Radiat Oncol Biol Phys. 2008 Sep 01; 72(1):201-9. PMID: 18722271.
      Citations: 5     Fields:    Translation:Humans
    239. Sawakuchi GO, Titt U, Mirkovic D, Mohan R. Density heterogeneities and the influence of multiple Coulomb and nuclear scatterings on the Bragg peak distal edge of proton therapy beams. Phys Med Biol. 2008 Sep 07; 53(17):4605-19. PMID: 18678928.
      Citations: 17     Fields:    Translation:Humans
    240. Titt U, Sahoo N, Ding X, Zheng Y, Newhauser WD, Zhu XR, Polf JC, Gillin MT, Mohan R. Assessment of the accuracy of an MCNPX-based Monte Carlo simulation model for predicting three-dimensional absorbed dose distributions. Phys Med Biol. 2008 Aug 21; 53(16):4455-70. PMID: 18670050.
      Citations: 22     Fields:    Translation:Humans
    241. Ezhil M, Starkschall G, Mohan R, Cox J, Komaki R. Validation of a model-based segmentation approach to propagating normal anatomic regions of interest through the 10 phases of respiration. Int J Radiat Oncol Biol Phys. 2008 Jul 01; 71(3):900-6. PMID: 18514782.
      Citations: 2     Fields:    Translation:Humans
    242. Harvey MC, Polf JC, Smith AR, Mohan R. Feasibility studies of a passive scatter proton therapy nozzle without a range modulator wheel. Med Phys. 2008 Jun; 35(6):2243-52. PMID: 18649454.
      Citations: 1     Fields:    
    243. Jang SY, Liu HH, Mohan R. Underestimation of low-dose radiation in treatment planning of intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys. 2008 Aug 01; 71(5):1537-46. PMID: 18513883.
      Citations: 14     Fields:    Translation:Humans
    244. Hui Z, Zhang X, Starkschall G, Li Y, Mohan R, Komaki R, Cox JD, Chang JY. Effects of interfractional motion and anatomic changes on proton therapy dose distribution in lung cancer. Int J Radiat Oncol Biol Phys. 2008 Dec 01; 72(5):1385-95. PMID: 18486357.
      Citations: 34     Fields:    Translation:Humans
    245. Wang H, Shiu A, Wang C, O'Daniel J, Mahajan A, Woo S, Liengsawangwong P, Mohan R, Chang EL. Dosimetric effect of translational and rotational errors for patients undergoing image-guided stereotactic body radiotherapy for spinal metastases. Int J Radiat Oncol Biol Phys. 2008 Jul 15; 71(4):1261-71. PMID: 18485614.
      Citations: 23     Fields:    Translation:HumansCTClinical Trials
    246. O'Daniel JC, Dong L, Zhang L, Wang H, Tucker SL, Kudchadker RJ, Lee AK, Cheung R, Cox JD, Kuban DA, Mohan R. Daily bone alignment with limited repeat CT correction rivals daily ultrasound alignment for prostate radiotherapy. Int J Radiat Oncol Biol Phys. 2008 May 01; 71(1):274-80. PMID: 18406891.
      Citations:    Fields:    Translation:Humans
    247. Yang M, Virshup G, Mohan R, Shaw CC, Zhu XR, Dong L. Improving accuracy of electron density measurement in the presence of metallic implants using orthovoltage computed tomography. Med Phys. 2008 May; 35(5):1932-41. PMID: 18561669.
      Citations: 3     Fields:    Translation:Humans
    248. Kry SF, Howell RM, Titt U, Salehpour M, Mohan R, Vassiliev ON. Energy spectra, sources, and shielding considerations for neutrons generated by a flattening filter-free Clinac. Med Phys. 2008 May; 35(5):1906-11. PMID: 18561666.
      Citations: 12     Fields:    Translation:Humans
    249. Li H, Zhu XR, Zhang L, Dong L, Tung S, Ahamad A, Chao KS, Morrison WH, Rosenthal DI, Schwartz DL, Mohan R, Garden AS. Comparison of 2D radiographic images and 3D cone beam computed tomography for positioning head-and-neck radiotherapy patients. Int J Radiat Oncol Biol Phys. 2008 Jul 01; 71(3):916-25. PMID: 18395358.
      Citations: 35     Fields:    Translation:Humans
    250. Newhauser WD, Giebeler A, Langen KM, Mirkovic D, Mohan R. Can megavoltage computed tomography reduce proton range uncertainties in treatment plans for patients with large metal implants? Phys Med Biol. 2008 May 07; 53(9):2327-44. PMID: 18421122.
      Citations: 27     Fields:    Translation:Humans
    251. Wijesooriya K, Weiss E, Dill V, Dong L, Mohan R, Joshi S, Keall PJ. Quantifying the accuracy of automated structure segmentation in 4D CT images using a deformable image registration algorithm. Med Phys. 2008 Apr; 35(4):1251-60. PMID: 18491517.
      Citations: 15     Fields:    Translation:Humans
    252. Tsunashima Y, Vedam S, Dong L, Umezawa M, Sakae T, Bues M, Balter P, Smith A, Mohan R. Efficiency of respiratory-gated delivery of synchrotron-based pulsed proton irradiation. Phys Med Biol. 2008 Apr 07; 53(7):1947-59. PMID: 18364549.
      Citations: 11     Fields:    Translation:Humans
    253. Wang S, Liao Z, Wei X, Liu HH, Tucker SL, Hu C, Ajani JA, Phan A, Swisher SG, Mohan R, Cox JD, Komaki R. Association between systemic chemotherapy before chemoradiation and increased risk of treatment-related pneumonitis in esophageal cancer patients treated with definitive chemoradiotherapy. J Thorac Oncol. 2008 Mar; 3(3):277-82. PMID: 18317071.
      Citations: 13     Fields:    Translation:Humans
    254. Chang JY, Dong L, Liu H, Starkschall G, Balter P, Mohan R, Liao Z, Cox JD, Komaki R. Image-guided radiation therapy for non-small cell lung cancer. J Thorac Oncol. 2008 Feb; 3(2):177-86. PMID: 18303441.
      Citations: 34     Fields:    Translation:Humans
    255. Wei X, Liu HH, Tucker SL, Wang S, Mohan R, Cox JD, Komaki R, Liao Z. Risk factors for pericardial effusion in inoperable esophageal cancer patients treated with definitive chemoradiation therapy. Int J Radiat Oncol Biol Phys. 2008 Mar 01; 70(3):707-14. PMID: 18191334.
      Citations: 65     Fields:    Translation:Humans
    256. Li Y, Zhang X, Lii M, Sahoo N, Zhu RX, Gillin M, Mohan R. Incorporating partial shining effects in proton pencil-beam dose calculation. Phys Med Biol. 2008 Feb 07; 53(3):605-16. PMID: 18199905.
      Citations: 4     Fields:    
    257. Wang X, Krishnan S, Zhang X, Dong L, Briere T, Crane CH, Martel M, Gillin M, Mohan R, Beddar S. Proton radiotherapy for liver tumors: dosimetric advantages over photon plans. Med Dosim. 2008; 33(4):259-67. PMID: 18973852.
      Citations: 31     Fields:    Translation:Humans
    258. Krishnan S, Briere TM, Dong L, Murthy R, Ng C, Balter P, Mohan R, Gillin MT, Beddar AS. Daily targeting of liver tumors: screening patients with a mock treatment and using a combination of internal and external fiducials for image-guided respiratory-gated radiotherapy. Med Phys. 2007 Dec; 34(12):4591-3. PMID: 18196785.
      Citations: 1     Fields:    Translation:Humans
    259. O'Daniel JC, Garden AS, Schwartz DL, Wang H, Ang KK, Ahamad A, Rosenthal DI, Morrison WH, Asper JA, Zhang L, Tung SM, Mohan R, Dong L. Parotid gland dose in intensity-modulated radiotherapy for head and neck cancer: is what you plan what you get? Int J Radiat Oncol Biol Phys. 2007 Nov 15; 69(4):1290-6. PMID: 17967319.
      Citations: 37     Fields:    Translation:Humans
    260. Vedam S, Archambault L, Starkschall G, Mohan R, Beddar S. Determination of prospective displacement-based gate threshold for respiratory-gated radiation delivery from retrospective phase-based gate threshold selected at 4D CT simulation. Med Phys. 2007 Nov; 34(11):4247-55. PMID: 18072489.
      Citations: 7     Fields:    Translation:Humans
    261. Melancon AD, O'Daniel JC, Zhang L, Kudchadker RJ, Kuban DA, Lee AK, Cheung RM, de Crevoisier R, Tucker SL, Newhauser WD, Mohan R, Dong L. Is a 3-mm intrafractional margin sufficient for daily image-guided intensity-modulated radiation therapy of prostate cancer? Radiother Oncol. 2007 Nov; 85(2):251-9. PMID: 17892900.
      Citations: 6     Fields:    Translation:Humans
    262. Lu J, Guerrero TM, Munro P, Jeung A, Chi PC, Balter P, Zhu XR, Mohan R, Pan T. Four-dimensional cone beam CT with adaptive gantry rotation and adaptive data sampling. Med Phys. 2007 Sep; 34(9):3520-9. PMID: 17926955.
      Citations: 51     Fields:    Translation:Humans
    263. Zhao KL, Liao Z, Bucci MK, Komaki R, Cox JD, Yu ZH, Zhang L, Mohan R, Dong L. Evaluation of respiratory-induced target motion for esophageal tumors at the gastroesophageal junction. Radiother Oncol. 2007 Sep; 84(3):283-9. PMID: 17716759.
      Citations: 22     Fields:    Translation:Humans
    264. Vassiliev ON, Titt U, Kry SF, Mohan R, Gillin MT. Radiation safety survey on a flattening filter-free medical accelerator. Radiat Prot Dosimetry. 2007; 124(2):187-90. PMID: 17681966.
      Citations: 5     Fields:    Translation:CellsPHPublic Health
    265. Kry SF, Titt U, Pönisch F, Vassiliev ON, Salehpour M, Gillin M, Mohan R. Reduced neutron production through use of a flattening-filter-free accelerator. Int J Radiat Oncol Biol Phys. 2007 Jul 15; 68(4):1260-4. PMID: 17637397.
      Citations: 21     Fields:    Translation:HumansCellsPHPublic Health
    266. Newhauser W, Fontenot J, Zheng Y, Polf J, Titt U, Koch N, Zhang X, Mohan R. Monte Carlo simulations for configuring and testing an analytical proton dose-calculation algorithm. Phys Med Biol. 2007 Aug 07; 52(15):4569-84. PMID: 17634651.
      Citations: 49     Fields:    
    267. Newhauser WD, Koch NC, Fontenot JD, Rosenthal SJ, S Gombos D, Fitzek MM, Mohan R. Dosimetric impact of tantalum markers used in the treatment of uveal melanoma with proton beam therapy. Phys Med Biol. 2007 Jul 07; 52(13):3979-90. PMID: 17664589.
      Citations: 19     Fields:    Translation:Humans
    268. de Crevoisier R, Melancon AD, Kuban DA, Lee AK, Cheung RM, Tucker SL, Kudchadker RJ, Newhauser WD, Zhang L, Mohan R, Dong L. Changes in the pelvic anatomy after an IMRT treatment fraction of prostate cancer. Int J Radiat Oncol Biol Phys. 2007 Aug 01; 68(5):1529-36. PMID: 17544595.
      Citations: 8     Fields:    Translation:Humans
    269. Chi PC, Mawlawi O, Nehmeh SA, Erdi YE, Balter PA, Luo D, Mohan R, Pan T. Design of respiration averaged CT for attenuation correction of the PET data from PET/CT. Med Phys. 2007 Jun; 34(6):2039-47. PMID: 17654907.
      Citations: 13     Fields:    
    270. Mason KA, Gillin MT, Mohan R, Cox JD. Preclinical biologic assessment of proton beam relative biologic effectiveness at Proton Therapy Center Houston. Int J Radiat Oncol Biol Phys. 2007 Jul 15; 68(4):968-70. PMID: 17512131.
      Citations: 5     Fields:    Translation:Animals
    271. Li Y, Zhang X, Dong L, Mohan R. A novel patch-field design using an optimized grid filter for passively scattered proton beams. Phys Med Biol. 2007 Jun 21; 52(12):N265-75. PMID: 17664545.
      Citations: 3     Fields:    Translation:Humans
    272. Newhauser W, Fontenot J, Koch N, Dong L, Lee A, Zheng Y, Waters L, Mohan R. Monte Carlo simulations of the dosimetric impact of radiopaque fiducial markers for proton radiotherapy of the prostate. Phys Med Biol. 2007 Jun 07; 52(11):2937-52. PMID: 17505081.
      Citations: 26     Fields:    Translation:Humans
    273. Shioyama Y, Jang SY, Liu HH, Guerrero T, Wang X, Gayed IW, Erwin WD, Liao Z, Chang JY, Jeter M, Yaremko BP, Borghero YO, Cox JD, Komaki R, Mohan R. Preserving functional lung using perfusion imaging and intensity-modulated radiation therapy for advanced-stage non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2007 Aug 01; 68(5):1349-58. PMID: 17446001.
      Citations: 31     Fields:    Translation:Humans
    274. Jang SY, Liu HH, Mohan R, Siebers JV. Variations in energy spectra and water-to-material stopping-power ratios in three-dimensional conformal and intensity-modulated photon fields. Med Phys. 2007 Apr; 34(4):1388-97. PMID: 17500470.
      Citations: 2     Fields:    Translation:Cells
    275. Liu HH, Balter P, Tutt T, Choi B, Zhang J, Wang C, Chi M, Luo D, Pan T, Hunjan S, Starkschall G, Rosen I, Prado K, Liao Z, Chang J, Komaki R, Cox JD, Mohan R, Dong L. Assessing respiration-induced tumor motion and internal target volume using four-dimensional computed tomography for radiotherapy of lung cancer. Int J Radiat Oncol Biol Phys. 2007 Jun 01; 68(2):531-40. PMID: 17398035.
      Citations: 99     Fields:    Translation:Humans
    276. Kang Y, Zhang X, Chang JY, Wang H, Wei X, Liao Z, Komaki R, Cox JD, Balter PA, Liu H, Zhu XR, Mohan R, Dong L. 4D Proton treatment planning strategy for mobile lung tumors. Int J Radiat Oncol Biol Phys. 2007 Mar 01; 67(3):906-14. PMID: 17293240.
      Citations: 79     Fields:    Translation:Humans
    277. Beddar AS, Kainz K, Briere TM, Tsunashima Y, Pan T, Prado K, Mohan R, Gillin M, Krishnan S. Correlation between internal fiducial tumor motion and external marker motion for liver tumors imaged with 4D-CT. Int J Radiat Oncol Biol Phys. 2007 Feb 01; 67(2):630-8. PMID: 17236980.
      Citations: 39     Fields:    Translation:Humans
    278. Zhang X, Dong L, Lee AK, Cox JD, Kuban DA, Zhu RX, Wang X, Li Y, Newhauser WD, Gillin M, Mohan R. Effect of anatomic motion on proton therapy dose distributions in prostate cancer treatment. Int J Radiat Oncol Biol Phys. 2007 Feb 01; 67(2):620-9. PMID: 17236979.
      Citations: 27     Fields:    Translation:Humans
    279. Cheung MR, Tucker SL, Dong L, de Crevoisier R, Lee AK, Frank S, Kudchadker RJ, Thames H, Mohan R, Kuban D. Investigation of bladder dose and volume factors influencing late urinary toxicity after external beam radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2007 Mar 15; 67(4):1059-65. PMID: 17241755.
      Citations: 27     Fields:    Translation:HumansPHPublic Health
    280. O'Daniel JC, Dong L, Zhang L, de Crevoisier R, Wang H, Lee AK, Cheung R, Tucker SL, Kudchadker RJ, Bonnen MD, Cox JD, Mohan R, Kuban DA. Dosimetric comparison of four target alignment methods for prostate cancer radiotherapy. Int J Radiat Oncol Biol Phys. 2006 Nov 01; 66(3):883-91. PMID: 17011461.
      Citations: 13     Fields:    Translation:Humans
    281. Jang SY, Liu HH, Wang X, Vassiliev ON, Siebers JV, Dong L, Mohan R. Dosimetric verification for intensity-modulated radiotherapy of thoracic cancers using experimental and Monte Carlo approaches. Int J Radiat Oncol Biol Phys. 2006 Nov 01; 66(3):939-48. PMID: 17011466.
      Citations: 4     Fields:    
    282. Wang S, Liao Z, Wei X, Liu HH, Tucker SL, Hu CS, Mohan R, Cox JD, Komaki R. Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT). Int J Radiat Oncol Biol Phys. 2006 Dec 01; 66(5):1399-407. PMID: 16997503.
      Citations: 125     Fields:    Translation:Humans
    283. Tucker SL, Liu HH, Wang S, Wei X, Liao Z, Komaki R, Cox JD, Mohan R. Dose-volume modeling of the risk of postoperative pulmonary complications among esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery. Int J Radiat Oncol Biol Phys. 2006 Nov 01; 66(3):754-61. PMID: 16965865.
      Citations: 27     Fields:    Translation:Humans
    284. Gao S, Zhang L, Wang H, de Crevoisier R, Kuban DD, Mohan R, Dong L. A deformable image registration method to handle distended rectums in prostate cancer radiotherapy. Med Phys. 2006 Sep; 33(9):3304-12. PMID: 17022225.
      Citations: 23     Fields:    Translation:HumansCTClinical Trials
    285. Chi PC, Balter P, Luo D, Mohan R, Pan T. Relation of external surface to internal tumor motion studied with cine CT. Med Phys. 2006 Sep; 33(9):3116-23. PMID: 17022203.
      Citations: 18     Fields:    Translation:Humans
    286. Keall PJ, Cattell H, Pokhrel D, Dieterich S, Wong KH, Murphy MJ, Vedam SS, Wijesooriya K, Mohan R. Geometric accuracy of a real-time target tracking system with dynamic multileaf collimator tracking system. Int J Radiat Oncol Biol Phys. 2006 Aug 01; 65(5):1579-84. PMID: 16863935.
      Citations: 39     Fields:    Translation:Humans
    287. Zhang X, Wang X, Dong L, Liu H, Mohan R. A sensitivity-guided algorithm for automated determination of IMRT objective function parameters. Med Phys. 2006 Aug; 33(8):2935-44. PMID: 16964872.
      Citations: 6     Fields:    Translation:HumansPHPublic Health
    288. George R, Chung TD, Vedam SS, Ramakrishnan V, Mohan R, Weiss E, Keall PJ. Audio-visual biofeedback for respiratory-gated radiotherapy: impact of audio instruction and audio-visual biofeedback on respiratory-gated radiotherapy. Int J Radiat Oncol Biol Phys. 2006 Jul 01; 65(3):924-33. PMID: 16751075.
      Citations: 60     Fields:    Translation:Humans
    289. Liu HH, Jauregui M, Zhang X, Wang X, Dong L, Mohan R. Beam angle optimization and reduction for intensity-modulated radiation therapy of non-small-cell lung cancers. Int J Radiat Oncol Biol Phys. 2006 Jun 01; 65(2):561-72. PMID: 16690438.
      Citations: 11     Fields:    Translation:Humans
    290. Pönisch F, Titt U, Vassiliev ON, Kry SF, Mohan R. Properties of unflattened photon beams shaped by a multileaf collimator. Med Phys. 2006 Jun; 33(6):1738-46. PMID: 16872081.
      Citations: 47     Fields:    Translation:HumansCells
    291. Titt U, Vassiliev ON, Pönisch F, Dong L, Liu H, Mohan R. A flattening filter free photon treatment concept evaluation with Monte Carlo. Med Phys. 2006 Jun; 33(6):1595-602. PMID: 16872067.
      Citations: 28     Fields:    
    292. Zhang L, Garden AS, Lo J, Ang KK, Ahamad A, Morrison WH, Rosenthal DI, Chambers MS, Zhu XR, Mohan R, Dong L. Multiple regions-of-interest analysis of setup uncertainties for head-and-neck cancer radiotherapy. Int J Radiat Oncol Biol Phys. 2006 Apr 01; 64(5):1559-69. PMID: 16580505.
      Citations: 46     Fields:    Translation:Humans
    293. Vassiliev ON, Titt U, Pönisch F, Kry SF, Mohan R, Gillin MT. Dosimetric properties of photon beams from a flattening filter free clinical accelerator. Phys Med Biol. 2006 Apr 07; 51(7):1907-17. PMID: 16552113.
      Citations: 58     Fields:    
    294. Tucker SL, Zhang M, Dong L, Mohan R, Kuban D, Thames HD. Cluster model analysis of late rectal bleeding after IMRT of prostate cancer: a case-control study. Int J Radiat Oncol Biol Phys. 2006 Mar 15; 64(4):1255-64. PMID: 16504763.
      Citations: 12     Fields:    Translation:HumansPHPublic Health
    295. Jang SY, Vassiliev ON, Liu HH, Mohan R, Siebers JV. Development and commissioning of a multileaf collimator model in monte carlo dose calculations for intensity-modulated radiation therapy. Med Phys. 2006 Mar; 33(3):770-81. PMID: 16878579.
      Citations: 8     Fields:    Translation:Humans
    296. Pönisch F, Titt U, Kry SF, Vassiliev ON, Mohan R. MCNPX simulation of a multileaf collimator. Med Phys. 2006 Feb; 33(2):402-4. PMID: 16532947.
      Citations: 4     Fields:    Translation:HumansPHPublic Health
    297. Fitzpatrick MJ, Starkschall G, Antolak JA, Fu J, Shukla H, Keall PJ, Klahr P, Mohan R. Displacement-based binning of time-dependent computed tomography image data sets. Med Phys. 2006 Jan; 33(1):235-46. PMID: 16485430.
      Citations: 16     Fields:    Translation:Humans
    298. Wang X, Zhang X, Dong L, Liu H, Gillin M, Ahamad A, Ang K, Mohan R. Effectiveness of noncoplanar IMRT planning using a parallelized multiresolution beam angle optimization method for paranasal sinus carcinoma. Int J Radiat Oncol Biol Phys. 2005 Oct 01; 63(2):594-601. PMID: 16168851.
      Citations: 37     Fields:    Translation:Humans
    299. Pan T, Mawlawi O, Nehmeh SA, Erdi YE, Luo D, Liu HH, Castillo R, Mohan R, Liao Z, Macapinlac HA. Attenuation correction of PET images with respiration-averaged CT images in PET/CT. J Nucl Med. 2005 Sep; 46(9):1481-7. PMID: 16157531.
      Citations: 68     Fields:    Translation:HumansCTClinical Trials
    300. de Crevoisier R, Tucker SL, Dong L, Mohan R, Cheung R, Cox JD, Kuban DA. Increased risk of biochemical and local failure in patients with distended rectum on the planning CT for prostate cancer radiotherapy. Int J Radiat Oncol Biol Phys. 2005 Jul 15; 62(4):965-73. PMID: 15989996.
      Citations: 83     Fields:    Translation:HumansPHPublic Health
    301. Wang H, Dong L, O'Daniel J, Mohan R, Garden AS, Ang KK, Kuban DA, Bonnen M, Chang JY, Cheung R. Validation of an accelerated 'demons' algorithm for deformable image registration in radiation therapy. Phys Med Biol. 2005 Jun 21; 50(12):2887-905. PMID: 15930609.
      Citations: 163     Fields:    Translation:Humans
    302. Court LE, Dong L, Lee AK, Cheung R, Bonnen MD, O'Daniel J, Wang H, Mohan R, Kuban D. An automatic CT-guided adaptive radiation therapy technique by online modification of multileaf collimator leaf positions for prostate cancer. Int J Radiat Oncol Biol Phys. 2005 May 01; 62(1):154-63. PMID: 15850916.
      Citations: 18     Fields:    Translation:Humans
    303. Beddar AS, Briere TM, Mourtada FA, Vassiliev ON, Liu HH, Mohan R. Monte Carlo calculations of the absorbed dose and energy dependence of plastic scintillators. Med Phys. 2005 May; 32(5):1265-9. PMID: 15984678.
      Citations: 4     Fields:    Translation:Cells
    304. Wu Q, Djajaputra D, Liu HH, Dong L, Mohan R, Wu Y. Dose sculpting with generalized equivalent uniform dose. Med Phys. 2005 May; 32(5):1387-96. PMID: 15984690.
      Citations: 10     Fields:    Translation:HumansPHPublic Health
    305. Mohan R, Zhang X, Wang H, Kang Y, Wang X, Liu H, Ang KK, Kuban D, Dong L. Use of deformed intensity distributions for on-line modification of image-guided IMRT to account for interfractional anatomic changes. Int J Radiat Oncol Biol Phys. 2005 Mar 15; 61(4):1258-66. PMID: 15752908.
      Citations: 33     Fields:    Translation:Humans
    306. Wang H, Dong L, Lii MF, Lee AL, de Crevoisier R, Mohan R, Cox JD, Kuban DA, Cheung R. Implementation and validation of a three-dimensional deformable registration algorithm for targeted prostate cancer radiotherapy. Int J Radiat Oncol Biol Phys. 2005 Mar 01; 61(3):725-35. PMID: 15708250.
      Citations: 51     Fields:    Translation:Humans
    307. George R, Keall PJ, Kini VR, Vedam SS, Ramakrishnan V, Mohan R. Is the diaphragm motion probability density function normally distributed? Med Phys. 2005 Feb; 32(2):396-404. PMID: 15789585.
      Citations: 4     Fields:    Translation:HumansCTClinical Trials
    308. Fitzpatrick MJ, Starkschall G, Balter P, Antolak JA, Guerrero T, Nelson C, Keall P, Mohan R. A novel platform simulating irregular motion to enhance assessment of respiration-correlated radiation therapy procedures. J Appl Clin Med Phys. 2005; 6(1):13-21. PMID: 15770194.
      Citations: 8     Fields:    
    309. Cho SH, Vassiliev ON, Lee S, Liu HH, Ibbott GS, Mohan R. Reference photon dosimetry data and reference phase space data for the 6 MV photon beam from varian clinac 2100 series linear accelerators. Med Phys. 2005 Jan; 32(1):137-48. PMID: 15719964.
      Citations: 19     Fields:    
    310. Keall PJ, Todor AD, Vedam SS, Bartee CL, Siebers JV, Kini VR, Mohan R. On the use of EPID-based implanted marker tracking for 4D radiotherapy. Med Phys. 2004 Dec; 31(12):3492-9. PMID: 15651632.
      Citations: 13     Fields:    Translation:Humans
    311. Lauve A, Morris M, Schmidt-Ullrich R, Wu Q, Mohan R, Abayomi O, Buck D, Holdford D, Dawson K, Dinardo L, Reiter E. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results. Int J Radiat Oncol Biol Phys. 2004 Oct 01; 60(2):374-87. PMID: 15380569.
      Citations: 42     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    312. Keall PJ, Siebers JV, Joshi S, Mohan R. Monte Carlo as a four-dimensional radiotherapy treatment-planning tool to account for respiratory motion. Phys Med Biol. 2004 Aug 21; 49(16):3639-48. PMID: 15446794.
      Citations: 20     Fields:    Translation:Humans
    313. Vedam SS, Keall PJ, Docef A, Todor DA, Kini VR, Mohan R. Predicting respiratory motion for four-dimensional radiotherapy. Med Phys. 2004 Aug; 31(8):2274-83. PMID: 15377094.
      Citations: 30     Fields:    Translation:Humans
    314. Thames HD, Zhang M, Tucker SL, Liu HH, Dong L, Mohan R. Cluster models of dose-volume effects. Int J Radiat Oncol Biol Phys. 2004 Aug 01; 59(5):1491-504. PMID: 15275737.
      Citations: 2     Fields:    Translation:AnimalsPHPublic Health
    315. Barker JL, Garden AS, Ang KK, O'Daniel JC, Wang H, Court LE, Morrison WH, Rosenthal DI, Chao KS, Tucker SL, Mohan R, Dong L. Quantification of volumetric and geometric changes occurring during fractionated radiotherapy for head-and-neck cancer using an integrated CT/linear accelerator system. Int J Radiat Oncol Biol Phys. 2004 Jul 15; 59(4):960-70. PMID: 15234029.
      Citations: 173     Fields:    Translation:Humans
    316. Tucker SL, Cheung R, Dong L, Liu HH, Thames HD, Huang EH, Kuban D, Mohan R. Dose-volume response analyses of late rectal bleeding after radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2004 Jun 01; 59(2):353-65. PMID: 15145148.
      Citations: 11     Fields:    Translation:HumansPHPublic Health
    317. Keall PJ, Starkschall G, Shukla H, Forster KM, Ortiz V, Stevens CW, Vedam SS, George R, Guerrero T, Mohan R. Acquiring 4D thoracic CT scans using a multislice helical method. Phys Med Biol. 2004 May 21; 49(10):2053-67. PMID: 15214541.
      Citations: 83     Fields:    Translation:Humans
    318. Zhang X, Liu H, Wang X, Dong L, Wu Q, Mohan R. Speed and convergence properties of gradient algorithms for optimization of IMRT. Med Phys. 2004 May; 31(5):1141-52. PMID: 15191303.
      Citations: 10     Fields:    Translation:HumansPHPublic Health
    319. Cheung R, Tucker SL, Ye JS, Dong L, Liu H, Huang E, Mohan R, Kuban D. Characterization of rectal normal tissue complication probability after high-dose external beam radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2004 Apr 01; 58(5):1513-9. PMID: 15050331.
      Citations: 15     Fields:    Translation:HumansPHPublic Health
    320. Liu HH, Wang X, Dong L, Wu Q, Liao Z, Stevens CW, Guerrero TM, Komaki R, Cox JD, Mohan R. Feasibility of sparing lung and other thoracic structures with intensity-modulated radiotherapy for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2004 Mar 15; 58(4):1268-79. PMID: 15001272.
      Citations: 51     Fields:    Translation:HumansPHPublic Health
    321. Lee HK, Vaporciyan AA, Cox JD, Tucker SL, Putnam JB, Ajani JA, Liao Z, Swisher SG, Roth JA, Smythe WR, Walsh GL, Mohan R, Liu HH, Mooring D, Komaki R. Postoperative pulmonary complications after preoperative chemoradiation for esophageal carcinoma: correlation with pulmonary dose-volume histogram parameters. Int J Radiat Oncol Biol Phys. 2003 Dec 01; 57(5):1317-22. PMID: 14630268.
      Citations: 38     Fields:    Translation:HumansPHPublic Health
    322. Shiu AS, Chang EL, Ye JS, Lii M, Rhines LD, Mendel E, Weinberg J, Singh S, Maor MH, Mohan R, Cox JD. Near simultaneous computed tomography image-guided stereotactic spinal radiotherapy: an emerging paradigm for achieving true stereotaxy. Int J Radiat Oncol Biol Phys. 2003 Nov 01; 57(3):605-13. PMID: 14529763.
      Citations: 20     Fields:    Translation:Humans
    323. Djajaputra D, Wu Q, Wu Y, Mohan R. Algorithm and performance of a clinical IMRT beam-angle optimization system. Phys Med Biol. 2003 Oct 07; 48(19):3191-212. PMID: 14579860.
      Citations: 14     Fields:    Translation:Humans
    324. Wu Q, Djajaputra D, Lauterbach M, Wu Y, Mohan R. A fast dose calculation method based on table lookup for IMRT optimization. Phys Med Biol. 2003 Jun 21; 48(12):N159-66. PMID: 12870589.
      Citations: 2     Fields:    Translation:Humans
    325. Wu Q, Mohan R, Morris M, Lauve A, Schmidt-Ullrich R. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas. I: dosimetric results. Int J Radiat Oncol Biol Phys. 2003 Jun 01; 56(2):573-85. PMID: 12738335.
      Citations: 75     Fields:    Translation:HumansCTClinical Trials
    326. Vedam SS, Kini VR, Keall PJ, Ramakrishnan V, Mostafavi H, Mohan R. Quantifying the predictability of diaphragm motion during respiration with a noninvasive external marker. Med Phys. 2003 Apr; 30(4):505-13. PMID: 12722802.
      Citations: 68     Fields:    Translation:HumansCTClinical Trials
    327. Wu Q, Djajaputra D, Wu Y, Zhou J, Liu HH, Mohan R. Intensity-modulated radiotherapy optimization with gEUD-guided dose-volume objectives. Phys Med Biol. 2003 Feb 07; 48(3):279-91. PMID: 12608607.
      Citations: 9     Fields:    Translation:HumansPHPublic Health
    328. Vedam SS, Keall PJ, Kini VR, Mostafavi H, Shukla HP, Mohan R. Acquiring a four-dimensional computed tomography dataset using an external respiratory signal. Phys Med Biol. 2003 Jan 07; 48(1):45-62. PMID: 12564500.
      Citations: 140     Fields:    Translation:Humans
    329. Keall PJ, Siebers JV, Jeraj R, Mohan R. Radiotherapy dose calculations in the presence of hip prostheses. Med Dosim. 2003; 28(2):107-12. PMID: 12804709.
      Citations: 14     Fields:    Translation:Humans
    330. Kini VR, Vedam SS, Keall PJ, Patil S, Chen C, Mohan R. Patient training in respiratory-gated radiotherapy. Med Dosim. 2003; 28(1):7-11. PMID: 12747612.
      Citations: 48     Fields:    Translation:Humans
    331. Siebers JV, Keall PJ, Kim JO, Mohan R. A method for photon beam Monte Carlo multileaf collimator particle transport. Phys Med Biol. 2002 Sep 07; 47(17):3225-49. PMID: 12361220.
      Citations: 20     Fields:    
    332. Wu Q, Mohan R. Multiple local minima in IMRT optimization based on dose-volume criteria. Med Phys. 2002 Jul; 29(7):1514-27. PMID: 12148734.
      Citations: 12     Fields:    Translation:Humans
    333. Kavanagh BD, Schefter TE, Wu Q, Tong S, Newman F, Arnfield M, Benedict SH, McCourt S, Mohan R. Clinical application of intensity-modulated radiotherapy for locally advanced cervical cancer. Semin Radiat Oncol. 2002 Jul; 12(3):260-71. PMID: 12118391.
      Citations: 13     Fields:    Translation:Humans
    334. Siebers JV, Lauterbach M, Keall PJ, Mohan R. Incorporating multi-leaf collimator leaf sequencing into iterative IMRT optimization. Med Phys. 2002 Jun; 29(6):952-9. PMID: 12094990.
      Citations: 18     Fields:    Translation:Humans
    335. Keall PJ, Kini VR, Vedam SS, Mohan R. Potential radiotherapy improvements with respiratory gating. Australas Phys Eng Sci Med. 2002 Mar; 25(1):1-6. PMID: 12049470.
      Citations: 20     Fields:    Translation:Humans
    336. Kim JO, Siebers JV, Keall PJ, Arnfield MR, Mohan R. A Monte Carlo study of radiation transport through multileaf collimators. Med Phys. 2001 Dec; 28(12):2497-506. PMID: 11797953.
      Citations: 14     Fields:    
    337. Manning MA, Wu Q, Cardinale RM, Mohan R, Lauve AD, Kavanagh BD, Morris MM, Schmidt-Ullrich RK. The effect of setup uncertainty on normal tissue sparing with IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2001 Dec 01; 51(5):1400-9. PMID: 11728701.
      Citations: 23     Fields:    Translation:Humans
    338. Hong JW, Liu JJ, Lee JS, Mohan RR, Mohan RR, Woods DJ, He YG, Wilson SE. Proinflammatory chemokine induction in keratocytes and inflammatory cell infiltration into the cornea. Invest Ophthalmol Vis Sci. 2001 Nov; 42(12):2795-803. PMID: 11687520.
      Citations: 48     Fields:    Translation:HumansCells
    339. Wilson SE, Mohan RR, Mohan RR, Ambrósio R, Hong J, Lee J. The corneal wound healing response: cytokine-mediated interaction of the epithelium, stroma, and inflammatory cells. Prog Retin Eye Res. 2001 Sep; 20(5):625-37. PMID: 11470453.
      Citations: 183     Fields:    Translation:HumansCells
    340. Wilson SE, Mohan RR, Hong JW, Lee JS, Choi R, Mohan RR. The wound healing response after laser in situ keratomileusis and photorefractive keratectomy: elusive control of biological variability and effect on custom laser vision correction. Arch Ophthalmol. 2001 Jun; 119(6):889-96. PMID: 11405841.
      Citations: 27     Fields:    Translation:HumansAnimalsCells
    341. Siebers JV, Tong S, Lauterbach M, Wu Q, Mohan R. Acceleration of dose calculations for intensity-modulated radiotherapy. Med Phys. 2001 Jun; 28(6):903-10. PMID: 11439487.
      Citations: 2     Fields:    Translation:Humans
    342. Keall PJ, Siebers JV, Arnfield M, Kim JO, Mohan R. Monte Carlo dose calculations for dynamic IMRT treatments. Phys Med Biol. 2001 Apr; 46(4):929-41. PMID: 11324969.
      Citations: 8     Fields:    Translation:Humans
    343. Mohan R, Antolak J. Monte Carlo techniques should replace analytical methods for estimating dose distributions in radiotherapy treatment planning. Med Phys. 2001 Feb; 28(2):123-6. PMID: 11243333.
      Citations: 4     Fields:    Translation:Humans
    344. Arnfield MR, Wu Q, Tong S, Mohan R. Dosimetric validation for multileaf collimator-based intensity-modulated radiotherapy: a review. Med Dosim. 2001; 26(2):179-88. PMID: 11444520.
      Citations: 6     Fields:    
    345. Mohan RR, Mohan RR, Wilson SE. Discoidin domain receptor (DDR) 1 and 2: collagen-activated tyrosine kinase receptors in the cornea. Exp Eye Res. 2001 Jan; 72(1):87-92. PMID: 11133186.
      Citations: 11     Fields:    Translation:HumansCells
    346. Keall PJ, Kini VR, Vedam SS, Mohan R. Motion adaptive x-ray therapy: a feasibility study. Phys Med Biol. 2001 Jan; 46(1):1-10. PMID: 11197664.
      Citations: 77     Fields:    Translation:Humans
    347. Arnfield MR, Siebers JV, Kim JO, Wu Q, Keall PJ, Mohan R. A method for determining multileaf collimator transmission and scatter for dynamic intensity modulated radiotherapy. Med Phys. 2000 Oct; 27(10):2231-41. PMID: 11099190.
      Citations: 16     Fields:    Translation:Humans
    348. Wu Q, Arnfield M, Tong S, Wu Y, Mohan R. Dynamic splitting of large intensity-modulated fields. Phys Med Biol. 2000 Jul; 45(7):1731-40. PMID: 10943915.
      Citations: 16     Fields:    
    349. Arnfield MR, Siantar CH, Siebers J, Garmon P, Cox L, Mohan R. The impact of electron transport on the accuracy of computed dose. Med Phys. 2000 Jun; 27(6):1266-74. PMID: 10902555.
      Citations: 22     Fields:    Translation:HumansCells
    350. Mohan R, Arnfield M, Tong S, Wu Q, Siebers J. The impact of fluctuations in intensity patterns on the number of monitor units and the quality and accuracy of intensity modulated radiotherapy. Med Phys. 2000 Jun; 27(6):1226-37. PMID: 10902551.
      Citations: 23     Fields:    Translation:Humans
    351. Mohan RR, Mohan RR, Kim WJ, Wilson SE. Modulation of TNF-alpha-induced apoptosis in corneal fibroblasts by transcription factor NF-kappaB. Invest Ophthalmol Vis Sci. 2000 May; 41(6):1327-36. PMID: 10798647.
      Citations: 33     Fields:    Translation:HumansCells
    352. Mohan RR, Mohan RR, Kim WJ, Stark GR, Wilson SE. Defective keratocyte apoptosis in response to epithelial injury in stat 1 null mice. Exp Eye Res. 2000 Apr; 70(4):485-91. PMID: 10865997.
      Citations: 9     Fields:    Translation:AnimalsCells
    353. Siebers JV, Keall PJ, Nahum AE, Mohan R. Converting absorbed dose to medium to absorbed dose to water for Monte Carlo based photon beam dose calculations. Phys Med Biol. 2000 Apr; 45(4):983-95. PMID: 10795986.
      Citations: 37     Fields:    Translation:Humans
    354. Keall PJ, Siebers JV, Jeraj R, Mohan R. The effect of dose calculation uncertainty on the evaluation of radiotherapy plans. Med Phys. 2000 Mar; 27(3):478-84. PMID: 10757600.
      Citations: 11     Fields:    Translation:Humans
    355. Mohan R, Wu Q, Manning M, Schmidt-Ullrich R. Radiobiological considerations in the design of fractionation strategies for intensity-modulated radiation therapy of head and neck cancers. Int J Radiat Oncol Biol Phys. 2000 Feb 01; 46(3):619-30. PMID: 10701741.
      Citations: 58     Fields:    Translation:Humans
    356. Wu Q, Manning M, Schmidt-Ullrich R, Mohan R. The potential for sparing of parotids and escalation of biologically effective dose with intensity-modulated radiation treatments of head and neck cancers: a treatment design study. Int J Radiat Oncol Biol Phys. 2000 Jan 01; 46(1):195-205. PMID: 10656393.
      Citations: 35     Fields:    Translation:Humans
    357. Siebers JV, Keall PJ, Libby B, Mohan R. Comparison of EGS4 and MCNP4b Monte Carlo codes for generation of photon phase space distributions for a Varian 2100C. Phys Med Biol. 1999 Dec; 44(12):3009-26. PMID: 10616151.
      Citations: 14     Fields:    
    358. Cardinale RM, Wu Q, Benedict SH, Kavanagh BD, Bump E, Mohan R. Determining the optimal block margin on the planning target volume for extracranial stereotactic radiotherapy. Int J Radiat Oncol Biol Phys. 1999 Sep 01; 45(2):515-20. PMID: 10487579.
      Citations: 5     Fields:    Translation:Humans
    359. Libby B, Siebers J, Mohan R. Validation of Monte Carlo generated phase-space descriptions of medical linear accelerators. Med Phys. 1999 Aug; 26(8):1476-83. PMID: 10501046.
      Citations: 7     Fields:    Translation:Humans
    360. Schach von Wittenau AE, Cox LJ, Bergstrom PM, Chandler WP, Hartmann Siantar CL, Mohan R. Correlated histogram representation of Monte Carlo derived medical accelerator photon-output phase space. Med Phys. 1999 Jul; 26(7):1196-211. PMID: 10435519.
      Citations: 4     Fields:    
    361. Kim WJ, Mohan RR, Mohan RR, Wilson SE. Effect of PDGF, IL-1alpha, and BMP2/4 on corneal fibroblast chemotaxis: expression of the platelet-derived growth factor system in the cornea. Invest Ophthalmol Vis Sci. 1999 Jun; 40(7):1364-72. PMID: 10359318.
      Citations: 43     Fields:    Translation:HumansCells
    362. Wilson SE, Liu JJ, Mohan RR. Stromal-epithelial interactions in the cornea. Prog Retin Eye Res. 1999 May; 18(3):293-309. PMID: 10192515.
      Citations: 87     Fields:    Translation:Humans
    363. Gupta S, Ahmad N, Mohan RR, Husain MM, Mukhtar H. Prostate cancer chemoprevention by green tea: in vitro and in vivo inhibition of testosterone-mediated induction of ornithine decarboxylase. Cancer Res. 1999 May 01; 59(9):2115-20. PMID: 10232597.
      Citations: 15     Fields:    Translation:HumansAnimalsCells
    364. Wilson SE, Chen L, Mohan RR, Liang Q, Liu J. Expression of HGF, KGF, EGF and receptor messenger RNAs following corneal epithelial wounding. Exp Eye Res. 1999 Apr; 68(4):377-97. PMID: 10192796.
      Citations: 47     Fields:    Translation:Animals
    365. Lahiri-Chatterjee M, Katiyar SK, Mohan RR, Agarwal R. A flavonoid antioxidant, silymarin, affords exceptionally high protection against tumor promotion in the SENCAR mouse skin tumorigenesis model. Cancer Res. 1999 Feb 01; 59(3):622-32. PMID: 9973210.
      Citations: 25     Fields:    Translation:AnimalsCells
    366. Kim WJ, Helena MC, Mohan RR, Wilson SE. Changes in corneal morphology associated with chronic epithelial injury. Invest Ophthalmol Vis Sci. 1999 Jan; 40(1):35-42. PMID: 9888424.
      Citations: 7     Fields:    Translation:Animals
    367. Mohan RR, Wilson SE. Ex vivo human corneal epithelial cells express membrane-bound precursor and mature soluble epidermal growth factor (EGF) and transforming growth factor (TGF) alpha proteins. Exp Eye Res. 1999 Jan; 68(1):129-31. PMID: 9986750.
      Citations: 3     Fields:    Translation:HumansCells
    368. Mohan RR, Challa A, Gupta S, Bostwick DG, Ahmad N, Agarwal R, Marengo SR, Amini SB, Paras F, MacLennan GT, Resnick MI, Mukhtar H. Overexpression of ornithine decarboxylase in prostate cancer and prostatic fluid in humans. Clin Cancer Res. 1999 Jan; 5(1):143-7. PMID: 9918212.
      Citations: 24     Fields:    Translation:Humans
    369. Mohan RR, Kim WJ, Mohan RR, Chen L, Wilson SE. Bone morphogenic proteins 2 and 4 and their receptors in the adult human cornea. Invest Ophthalmol Vis Sci. 1998 Dec; 39(13):2626-36. PMID: 9856772.
      Citations: 22     Fields:    Translation:HumansCells
    370. Liang Q, Mohan RR, Chen L, Wilson SE. Signaling by HGF and KGF in corneal epithelial cells: Ras/MAP kinase and Jak-STAT pathways. Invest Ophthalmol Vis Sci. 1998 Jul; 39(8):1329-38. PMID: 9660480.
      Citations: 12     Fields:    Translation:HumansCells
    371. Cotrutz C, Kappas C, Theodorakos Y, Makris C, Mohan R. Development in a Windows environment of a radiation treatment planning system for personal computers. Comput Methods Programs Biomed. 1998 Jun; 56(3):261-72. PMID: 9725651.
      Citations:    Fields:    Translation:Humans
    372. Reinstein LE, Wang XH, Burman CM, Chen Z, Mohan R, Kutcher G, Leibel SA, Fuks Z. A feasibility study of automated inverse treatment planning for cancer of the prostate. Int J Radiat Oncol Biol Phys. 1998 Jan 01; 40(1):207-14. PMID: 9422578.
      Citations: 5     Fields:    Translation:Humans
    373. Mohan R, Mageras G, Wu Q. Computer-controlled delivery of 3D conformal radiation treatments. Cancer Treat Res. 1998; 93:49-67. PMID: 9513776.
      Citations:    Fields:    Translation:Humans
    374. Burman C, Chui CS, Kutcher G, Leibel S, Zelefsky M, LoSasso T, Spirou S, Wu Q, Yang J, Stein J, Mohan R, Fuks Z, Ling CC. Planning, delivery, and quality assurance of intensity-modulated radiotherapy using dynamic multileaf collimator: a strategy for large-scale implementation for the treatment of carcinoma of the prostate. Int J Radiat Oncol Biol Phys. 1997 Nov 01; 39(4):863-73. PMID: 9369136.
      Citations: 39     Fields:    Translation:Humans
    375. Mohan RR, Liang Q, Kim WJ, Helena MC, Baerveldt F, Wilson SE. Apoptosis in the cornea: further characterization of Fas/Fas ligand system. Exp Eye Res. 1997 Oct; 65(4):575-89. PMID: 9464190.
      Citations: 36     Fields:    Translation:AnimalsCells
    376. Weng J, Mohan RR, Li Q, Wilson SE. IL-1 upregulates keratinocyte growth factor and hepatocyte growth factor mRNA and protein production by cultured stromal fibroblast cells: interleukin-1 beta expression in the cornea. Cornea. 1997 Jul; 16(4):465-71. PMID: 9220246.
      Citations: 29     Fields:    Translation:HumansAnimalsCells
    377. Weng J, Liang Q, Mohan RR, Li Q, Wilson SE. Hepatocyte growth factor, keratinocyte growth factor, and other growth factor-receptor systems in the lens. Invest Ophthalmol Vis Sci. 1997 Jul; 38(8):1543-54. PMID: 9224282.
      Citations: 8     Fields:    Translation:HumansAnimalsCells
    378. Katiyar SK, Mohan RR, Agarwal R, Mukhtar H. Protection against induction of mouse skin papillomas with low and high risk of conversion to malignancy by green tea polyphenols. Carcinogenesis. 1997 Mar; 18(3):497-502. PMID: 9067548.
      Citations: 11     Fields:    Translation:Animals
    379. Stein J, Mohan R, Wang XH, Bortfeld T, Wu Q, Preiser K, Ling CC, Schlegel W. Number and orientations of beams in intensity-modulated radiation treatments. Med Phys. 1997 Feb; 24(2):149-60. PMID: 9048355.
      Citations: 22     Fields:    Translation:Humans
    380. Malataras G, Kappas C, Lovelock DM, Mohan R. Simulation with EGS4 code of external beam of radiotherapy apparatus with workstation and PC gives similar results? Comput Methods Programs Biomed. 1997 Jan; 52(1):45-51. PMID: 9034669.
      Citations:    Fields:    Translation:Humans
    381. Mohan R, Wu Q, Wang X, Stein J. Intensity modulation optimization, lateral transport of radiation, and margins. Med Phys. 1996 Dec; 23(12):2011-21. PMID: 8994166.
      Citations: 1     Fields:    Translation:Humans
    382. Agarwal R, Mohan RR, Ahmad N, Mukhtar H. Protection against malignant conversion in SENCAR mouse skin by all trans retinoic acid: inhibition of the ras p21-processing enzyme farnesyltransferase and Ha-ras p21 membrane localization. Mol Carcinog. 1996 Sep; 17(1):13-22. PMID: 8876671.
      Citations:    Fields:    Translation:AnimalsCells
    383. Singh SV, Mohan RR, Agarwal R, Benson PJ, Hu X, Rudy MA, Xia H, Katoh A, Srivastava SK, Mukhtar H, Gupta V, Zaren HA. Novel anti-carcinogenic activity of an organosulfide from garlic: inhibition of H-RAS oncogene transformed tumor growth in vivo by diallyl disulfide is associated with inhibition of p21H-ras processing. Biochem Biophys Res Commun. 1996 Aug 14; 225(2):660-5. PMID: 8753815.
      Citations: 12     Fields:    Translation:AnimalsCells
    384. Bortfeld T, Schlegel W, Dykstra C, Levegrün S, Preiser K. Physical vs. biological objectives for treatment plan optimization. Radiother Oncol. 1996 Aug; 40(2):185-7. PMID: 8884974.
      Citations:    Fields:    Translation:Humans
    385. Ling CC, Burman C, Chui CS, Kutcher GJ, Leibel SA, LoSasso T, Mohan R, Bortfeld T, Reinstein L, Spirou S, Wang XH, Wu Q, Zelefsky M, Fuks Z. Conformal radiation treatment of prostate cancer using inversely-planned intensity-modulated photon beams produced with dynamic multileaf collimation. Int J Radiat Oncol Biol Phys. 1996 Jul 01; 35(4):721-30. PMID: 8690638.
      Citations: 53     Fields:    Translation:Humans
    386. Mageras GS, Kutcher GJ, Leibel SA, Zelefsky MJ, Melian E, Mohan R, Fuks Z. A method of incorporating organ motion uncertainties into three-dimensional conformal treatment plans. Int J Radiat Oncol Biol Phys. 1996 May 01; 35(2):333-42. PMID: 8635941.
      Citations: 5     Fields:    Translation:Humans
    387. Agarwal R, Korman NJ, Mohan RR, Feyes DK, Jawed S, Zaim MT, Mukhtar H. Apoptosis is an early event during phthalocyanine photodynamic therapy-induced ablation of chemically induced squamous papillomas in mouse skin. Photochem Photobiol. 1996 Apr; 63(4):547-52. PMID: 8934768.
      Citations: 9     Fields:    Translation:Animals
    388. Khan SG, Mohan RR, Katiyar SK, Wood GS, Bickers DR, Mukhtar H, Agarwal R. Mutations in ras oncogenes: rare events in ultraviolet B radiation-induced mouse skin tumorigenesis. Mol Carcinog. 1996 Feb; 15(2):96-103. PMID: 8599584.
      Citations: 4     Fields:    Translation:AnimalsCellsPHPublic Health
    389. Mohan R, Wang X, Jackson A. Optimization of 3-D conformal radiation treatment plans. Front Radiat Ther Oncol. 1996; 29:86-103. PMID: 8742891.
      Citations:    Fields:    Translation:Humans
    390. Leibel SA, Kutcher GJ, Zelefsky MJ, Burman CM, Mohan R, Ling CC, Fuks Z. 3-D conformal radiotherapy for carcinoma of the prostate. Clinical experience at the Memorial Sloan-Kettering Cancer Center. Front Radiat Ther Oncol. 1996; 29:229-37. PMID: 8742903.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    391. Leibel SA, Armstrong JG, Kutcher GJ, Zelefsky MJ, Burman CM, Mohan R, Ling CC, Fuks Z. 3-D conformal radiation therapy for non-small cell lung carcinoma. Clinical experience at the Memorial Sloan-Kettering Cancer Center. Front Radiat Ther Oncol. 1996; 29:199-206. PMID: 8742900.
      Citations: 2     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    392. Mohan R, Lovelock M, Mageras G, LoSasso T, Chui C. Computer-controlled radiation therapy and multileaf collimation. Front Radiat Ther Oncol. 1996; 29:123-38. PMID: 8742894.
      Citations:    Fields:    Translation:Humans
    393. Brewster L, Mohan R, Mageras G, Burman C, Leibel S, Fuks Z. Three dimensional conformal treatment planning with multileaf collimators. Int J Radiat Oncol Biol Phys. 1995 Dec 01; 33(5):1081-9. PMID: 7493834.
      Citations: 2     Fields:    Translation:Humans
    394. Wang XH, Mohan R, Jackson A, Leibel SA, Fuks Z, Ling CC. Optimization of intensity-modulated 3D conformal treatment plans based on biological indices. Radiother Oncol. 1995 Nov; 37(2):140-52. PMID: 8747939.
      Citations: 3     Fields:    Translation:Humans
    395. Chen Z, Wang X, Bortfeld T, Mohan R, Reinstein L. The influence of scatter on the design of optimized intensity modulations. Med Phys. 1995 Nov; 22(11 Pt 1):1727-33. PMID: 8587525.
      Citations: 2     Fields:    Translation:Humans
    396. Lovelock DM, Chui CS, Mohan R. A Monte Carlo model of photon beams used in radiation therapy. Med Phys. 1995 Sep; 22(9):1387-94. PMID: 8531863.
      Citations: 8     Fields:    Translation:Humans
    397. Masterson ME, Chui CS, Febo R, Hung JD, Fuks Z, Mohan R, Ling CC, Kutcher GJ, Bjork S, Enstrom J. Beam characteristics of a new generation 50 MeV racetrack microtron. Med Phys. 1995 Jun; 22(6):781-92. PMID: 7565367.
      Citations:    Fields:    Translation:Humans
    398. Mageras GS, Fuks Z, O'Brien J, Brewster LJ, Burman C, Chui CS, Leibel SA, Ling CC, Masterson ME, Mohan R, et al. Initial clinical experience with computer-controlled conformal radiotherapy of the prostate using a 50-MeV medical microtron. Int J Radiat Oncol Biol Phys. 1994 Nov 15; 30(4):971-8. PMID: 7961001.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    399. Leibel SA, Zelefsky MJ, Kutcher GJ, Burman CM, Mohan R, Mageras GS, Ling CC, Fuks Z. The biological basis and clinical application of three-dimensional conformal external beam radiation therapy in carcinoma of the prostate. Semin Oncol. 1994 Oct; 21(5):580-97. PMID: 7939749.
      Citations: 6     Fields:    Translation:Humans
    400. Mohan R, Wang X, Jackson A, Bortfeld T, Boyer AL, Kutcher GJ, Leibel SA, Fuks Z, Ling CC. The potential and limitations of the inverse radiotherapy technique. Radiother Oncol. 1994 Sep; 32(3):232-48. PMID: 7816942.
      Citations: 11     Fields:    Translation:Humans
    401. Leibel SA, Heimann R, Kutcher GJ, Zelefsky MJ, Burman CM, Melian E, Orazem JP, Mohan R, LoSasso TJ, Lo YC, et al. Three-dimensional conformal radiation therapy in locally advanced carcinoma of the prostate: preliminary results of a phase I dose-escalation study. Int J Radiat Oncol Biol Phys. 1994 Jan 01; 28(1):55-65. PMID: 7505776.
      Citations: 5     Fields:    Translation:HumansCTClinical Trials
    402. Brewster L, Mageras GS, Mohan R. Automatic generation of beam apertures. Med Phys. 1993 Sep-Oct; 20(5):1337-42. PMID: 8289714.
      Citations:    Fields:    Translation:Humans
    403. Sgouros G, Chiu S, Pentlow KS, Brewster LJ, Kalaigian H, Baldwin B, Daghighian F, Graham MC, Larson SM, Mohan R. Three-dimensional dosimetry for radioimmunotherapy treatment planning. J Nucl Med. 1993 Sep; 34(9):1595-601. PMID: 8394886.
      Citations: 9     Fields:    Translation:Humans
    404. Jackson A, Mohan R, Baldwin B. Comments on "Sampling techniques for the evaluation of treatment plans" [Med. Phys. 20, 151-161 (1993)]. Med Phys. 1993 Sep-Oct; 20(5):1375-6; author reply 1381-5. PMID: 8289719.
      Citations:    Fields:    Translation:Humans
    405. Mageras GS, Mohan R. Application of fast simulated annealing to optimization of conformal radiation treatments. Med Phys. 1993 May-Jun; 20(3):639-47. PMID: 8350815.
      Citations: 7     Fields:    Translation:Humans
    406. Kutcher GJ, Leibel SA, Mohan R, Harrison LB, Armstrong JG, Zelefsky MF, LoSasso TJ, Burman CM, Mageras GS, Chui CS, et al. Advances in precision treatment: some aspects of 3D conformal radiation therapy. Front Radiat Ther Oncol. 1993; 27:209-26. PMID: 8504948.
      Citations: 1     Fields:    Translation:Humans
    407. Mageras GS, Podmaniczky KC, Mohan R. A model for computer-controlled delivery of 3-D conformal treatments. Med Phys. 1992 Jul-Aug; 19(4):945-53. PMID: 1518483.
      Citations: 2     Fields:    Translation:Humans
    408. Mohan R, Mageras GS, Baldwin B, Brewster LJ, Kutcher GJ, Leibel S, Burman CM, Ling CC, Fuks Z. Clinically relevant optimization of 3-D conformal treatments. Med Phys. 1992 Jul-Aug; 19(4):933-44. PMID: 1518482.
      Citations: 27     Fields:    Translation:Humans
    409. Leibel SA, Ling CC, Kutcher GJ, Mohan R, Cordon-Cordo C, Fuks Z. The biological basis for conformal three-dimensional radiation therapy. Int J Radiat Oncol Biol Phys. 1991 Aug; 21(3):805-11. PMID: 1869471.
      Citations: 5     Fields:    Translation:Humans
    410. Simpson JR, Purdy JA, Manolis JM, Pilepich MV, Burman C, Forman J, Fuks Z, Cheng E, Chu J, Matthews J, et al. Three-dimensional treatment planning considerations for prostate cancer. Int J Radiat Oncol Biol Phys. 1991 May 15; 21(1):243-52. PMID: 2032892.
      Citations: 2     Fields:    Translation:Humans
    411. Munzenrider JE, Brown AP, Chu JC, Coia LR, Doppke KP, Emami B, Kutcher GJ, Mohan R, Purdy JA, Shank B, et al. Numerical scoring of treatment plans. Int J Radiat Oncol Biol Phys. 1991 May 15; 21(1):147-63. PMID: 1903371.
      Citations: 1     Fields:    Translation:Humans
    412. Masterson ME, Barest G, Chui CS, Doppke KP, Epperson RD, Harms WB, Krippner KE, Mohan R, Slessinger ED, Sontag MR, et al. Interinstitutional experience in verification of external photon dose calculations. Int J Radiat Oncol Biol Phys. 1991 May 15; 21(1):37-58. PMID: 2032896.
      Citations:    Fields:    Translation:Humans
    413. Drzymala RE, Mohan R, Brewster L, Chu J, Goitein M, Harms W, Urie M. Dose-volume histograms. Int J Radiat Oncol Biol Phys. 1991 May 15; 21(1):71-8. PMID: 2032898.
      Citations: 48     Fields:    Translation:Humans
    414. Kutcher GJ, Fuks Z, Brenner H, Brown AP, Burman C, Cheng E, Coia L, Krippner K, Manolis JM, Mohan R, et al. Three-dimensional photon treatment planning for carcinoma of the nasopharynx. Int J Radiat Oncol Biol Phys. 1991 May 15; 21(1):169-82. PMID: 2032886.
      Citations: 2     Fields:    Translation:Humans
    415. Coia L, Galvin J, Sontag M, Blitzer P, Brenner H, Cheng E, Doppke K, Harms W, Hunt M, Mohan R, et al. Three-dimensional photon treatment planning in carcinoma of the larynx. Int J Radiat Oncol Biol Phys. 1991 May 15; 21(1):183-92. PMID: 2032887.
      Citations:    Fields:    Translation:Humans
    416. Mageras GS, Mohan R, Burman C, Barest GD, Kutcher GJ. Compensators for three-dimensional treatment planning. Med Phys. 1991 Mar-Apr; 18(2):133-40. PMID: 2046597.
      Citations: 4     Fields:    Translation:Humans
    417. Fuks Z, Leibel SA, Kutcher GJ, Mohan R, Ling CC. Three-dimensional conformal treatment: a new frontier in radiation therapy. Important Adv Oncol. 1991; 151-72. PMID: 1869275.
      Citations: 2     Fields:    Translation:Humans
    418. Kutcher GJ, Burman C, Mohan R. Compensation in three-dimensional non-coplanar treatment planning. Int J Radiat Oncol Biol Phys. 1991 Jan; 20(1):127-33. PMID: 1993620.
      Citations: 4     Fields:    Translation:Humans
    419. Mohan R. Dose computations for three-dimensional radiation treatment planning. Australas Phys Eng Sci Med. 1989 Dec; 12(4):241-51. PMID: 2610640.
      Citations:    Fields:    
    420. Mohan R. Three-dimensional radiation treatment planning. Australas Phys Eng Sci Med. 1989 Jun; 12(2):73-91. PMID: 2764798.
      Citations:    Fields:    
    421. Mohan R, Brewster LJ, Barest GD, Chui CS. Computer graphics tools for radiation treatment planning. Comput Methods Programs Biomed. 1989 Mar; 28(3):157-70. PMID: 2702808.
      Citations:    Fields:    Translation:Humans
    422. Mohan R, Barest G, Brewster LJ, Chui CS, Kutcher GJ, Laughlin JS, Fuks Z. A comprehensive three-dimensional radiation treatment planning system. Int J Radiat Oncol Biol Phys. 1988 Aug; 15(2):481-95. PMID: 3403328.
      Citations: 28     Fields:    Translation:Humans
    423. Chui CS, Mohan R. Extraction of pencil beam kernels by the deconvolution method. Med Phys. 1988 Mar-Apr; 15(2):138-44. PMID: 3386581.
      Citations: 1     Fields:    Translation:Humans
    424. Mohan R, Chui CS, Fontenla D, Han K, Ballon D. The effect of angular spread on the intensity distribution of arbitrarily shaped electron beams. Med Phys. 1988 Mar-Apr; 15(2):204-10. PMID: 3386590.
      Citations: 2     Fields:    Translation:Humans
    425. Mohan R, Brewster LJ, Barest G, Ding IY, Chui CS, Shank B, Vikram B. Arbitrary oblique image sections for 3-D radiation treatment planning. Int J Radiat Oncol Biol Phys. 1987 Aug; 13(8):1247-54. PMID: 3610712.
      Citations:    Fields:    Translation:Humans
    426. Han K, Ballon D, Chui C, Mohan R. Monte Carlo simulation of a cobalt-60 beam. Med Phys. 1987 May-Jun; 14(3):414-9. PMID: 3600534.
      Citations: 3     Fields:    Translation:Humans
    427. Mohan R, Chui CS. Validity of the concept of separating primary and scatter dose. Med Phys. 1985 Nov-Dec; 12(6):726-30. PMID: 4079863.
      Citations: 1     Fields:    Translation:Humans
    428. Mohan R, Chui C, Lidofsky L. Energy and angular distributions of photons from medical linear accelerators. Med Phys. 1985 Sep-Oct; 12(5):592-7. PMID: 4046993.
      Citations: 22     Fields:    Translation:HumansCells
    429. Podmaniczky KC, Mohan R, Kutcher GJ, Kestler C, Vikram B. Clinical experience with a computerized record and verify system. Int J Radiat Oncol Biol Phys. 1985 Aug; 11(8):1529-37. PMID: 4019277.
      Citations: 3     Fields:    Translation:Humans
    430. Mohan R, Ding IY, Toraskar J, Chui C, Anderson LL, Nori D. Computation of radiation dose distributions for shielded cervical applicators. Int J Radiat Oncol Biol Phys. 1985 Apr; 11(4):823-30. PMID: 3980278.
      Citations:    Fields:    Translation:Humans